#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=The impact of psychosis genome-wide associated ZNF804A variation on verbal fluency connectivity
#Text=Schizophrenia (SCZ) and bipolar disorder (BD) have high heritability.
1-1	0-3	The	_	
1-2	4-10	impact	_	
1-3	11-13	of	_	
1-4	14-23	psychosis	_	
1-5	24-35	genome-wide	_	
1-6	36-46	associated	_	
1-7	47-54	ZNF804A	_	
1-8	55-64	variation	_	
1-9	65-67	on	_	
1-10	68-74	verbal	_	
1-11	75-82	fluency	_	
1-12	83-95	connectivity	_	
1-13	96-109	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-14	110-111	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-15	111-114	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-16	114-115	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-17	116-119	and	_	
1-18	120-127	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[2]	
1-19	128-136	disorder	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[2]	
1-20	137-138	(	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[2]	
1-21	138-140	BD	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[2]	
1-22	140-141	)	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[2]	
1-23	142-146	have	_	
1-24	147-151	high	_	
1-25	152-164	heritability	_	
1-26	164-165	.	_	

#Text=Genome-wide association studies (GWAS) have identified ZNF804A as a significant risk gene for both illnesses.
2-1	166-177	Genome-wide	_	
2-2	178-189	association	_	
2-3	190-197	studies	_	
2-4	198-199	(	_	
2-5	199-203	GWAS	_	
2-6	203-204	)	_	
2-7	205-209	have	_	
2-8	210-220	identified	_	
2-9	221-228	ZNF804A	_	
2-10	229-231	as	_	
2-11	232-233	a	_	
2-12	234-245	significant	_	
2-13	246-250	risk	_	
2-14	251-255	gene	_	
2-15	256-259	for	_	
2-16	260-264	both	_	
2-17	265-274	illnesses	_	
2-18	274-275	.	_	

#Text=A validation of this finding at the brain systems-level is imperative as there is still little understanding of how it heightens risk.
3-1	276-277	A	_	
3-2	278-288	validation	_	
3-3	289-291	of	_	
3-4	292-296	this	_	
3-5	297-304	finding	_	
3-6	305-307	at	_	
3-7	308-311	the	_	
3-8	312-317	brain	_	
3-9	318-331	systems-level	_	
3-10	332-334	is	_	
3-11	335-345	imperative	_	
3-12	346-348	as	_	
3-13	349-354	there	_	
3-14	355-357	is	_	
3-15	358-363	still	_	
3-16	364-370	little	_	
3-17	371-384	understanding	_	
3-18	385-387	of	_	
3-19	388-391	how	_	
3-20	392-394	it	_	
3-21	395-404	heightens	_	
3-22	405-409	risk	_	
3-23	409-410	.	_	

#Text=Based in part on our recent findings of an effect on widespread decreased white matter microstructural fractional anisotropy (putatively a proxy of its integrity), particularly strong in SCZ, we asked whether the risk allele has a detrimental effect on regional brain activation and functional connectivity during a type of cognitive processing which is, together with its neural correlates, impaired in BD and SCZ: verbal fluency.
4-1	411-416	Based	_	
4-2	417-419	in	_	
4-3	420-424	part	_	
4-4	425-427	on	_	
4-5	428-431	our	_	
4-6	432-438	recent	_	
4-7	439-447	findings	_	
4-8	448-450	of	_	
4-9	451-453	an	_	
4-10	454-460	effect	_	
4-11	461-463	on	_	
4-12	464-474	widespread	_	
4-13	475-484	decreased	_	
4-14	485-490	white	_	
4-15	491-497	matter	_	
4-16	498-513	microstructural	_	
4-17	514-524	fractional	_	
4-18	525-535	anisotropy	_	
4-19	536-537	(	_	
4-20	537-547	putatively	_	
4-21	548-549	a	_	
4-22	550-555	proxy	_	
4-23	556-558	of	_	
4-24	559-562	its	_	
4-25	563-572	integrity	_	
4-26	572-573	)	_	
4-27	573-574	,	_	
4-28	575-587	particularly	_	
4-29	588-594	strong	_	
4-30	595-597	in	_	
4-31	598-601	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
4-32	601-602	,	_	
4-33	603-605	we	_	
4-34	606-611	asked	_	
4-35	612-619	whether	_	
4-36	620-623	the	_	
4-37	624-628	risk	_	
4-38	629-635	allele	_	
4-39	636-639	has	_	
4-40	640-641	a	_	
4-41	642-653	detrimental	_	
4-42	654-660	effect	_	
4-43	661-663	on	_	
4-44	664-672	regional	_	
4-45	673-678	brain	_	
4-46	679-689	activation	_	
4-47	690-693	and	_	
4-48	694-704	functional	_	
4-49	705-717	connectivity	_	
4-50	718-724	during	_	
4-51	725-726	a	_	
4-52	727-731	type	_	
4-53	732-734	of	_	
4-54	735-744	cognitive	_	
4-55	745-755	processing	_	
4-56	756-761	which	_	
4-57	762-764	is	_	
4-58	764-765	,	_	
4-59	766-774	together	_	
4-60	775-779	with	_	
4-61	780-783	its	_	
4-62	784-790	neural	_	
4-63	791-801	correlates	_	
4-64	801-802	,	_	
4-65	803-811	impaired	_	
4-66	812-814	in	_	
4-67	815-817	BD	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder	
4-68	818-821	and	_	
4-69	822-825	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
4-70	825-826	:	_	
4-71	827-833	verbal	_	
4-72	834-841	fluency	_	
4-73	841-842	.	_	

#Text=Functional MRI and genotype data was collected from 80 healthy volunteers, and 54 SCZ and 40 BD patients.
5-1	843-853	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[3]	
5-2	854-857	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[3]	
5-3	858-861	and	_	
5-4	862-870	genotype	_	
5-5	871-875	data	_	
5-6	876-879	was	_	
5-7	880-889	collected	_	
5-8	890-894	from	_	
5-9	895-897	80	_	
5-10	898-905	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
5-11	906-916	volunteers	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
5-12	916-917	,	_	
5-13	918-921	and	_	
5-14	922-924	54	_	
5-15	925-928	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
5-16	929-932	and	_	
5-17	933-935	40	_	
5-18	936-938	BD	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder	
5-19	939-947	patients	_	
5-20	947-948	.	_	

#Text=A standard multifactorial analysis of variance using statistical parametric mapping and significance correction of FWE p < 0.05 was used.
6-1	949-950	A	_	
6-2	951-959	standard	_	
6-3	960-974	multifactorial	_	
6-4	975-983	analysis	_	
6-5	984-986	of	_	
6-6	987-995	variance	_	
6-7	996-1001	using	_	
6-8	1002-1013	statistical	_	
6-9	1014-1024	parametric	_	
6-10	1025-1032	mapping	_	
6-11	1033-1036	and	_	
6-12	1037-1049	significance	_	
6-13	1050-1060	correction	_	
6-14	1061-1063	of	_	
6-15	1064-1067	FWE	_	
6-16	1068-1069	p	_	
6-17	1069-1070	 	_	
6-18	1070-1071	<	_	
6-19	1071-1072	 	_	
6-20	1072-1076	0.05	_	
6-21	1077-1080	was	_	
6-22	1081-1085	used	_	
6-23	1085-1086	.	_	

#Text=We found the GWAS risk allele A was associated with decreased positive functional coupling between the left precentral gyrus/inferior frontal gyrus (i.e. the most highly recruited area for the task) and: 1) the left inferior frontal gyrus, and 2) the left posterior cingulate gyrus, encompassing the precuneus; both as a main effect across controls and psychosis patients.
7-1	1087-1089	We	_	
7-2	1090-1095	found	_	
7-3	1096-1099	the	_	
7-4	1100-1104	GWAS	_	
7-5	1105-1109	risk	_	
7-6	1110-1116	allele	_	
7-7	1117-1118	A	_	
7-8	1119-1122	was	_	
7-9	1123-1133	associated	_	
7-10	1134-1138	with	_	
7-11	1139-1148	decreased	_	
7-12	1149-1157	positive	_	
7-13	1158-1168	functional	_	
7-14	1169-1177	coupling	_	
7-15	1178-1185	between	_	
7-16	1186-1189	the	_	
7-17	1190-1194	left	_	
7-18	1195-1205	precentral	_	
7-19	1206-1211	gyrus	_	
7-20	1211-1212	/	_	
7-21	1212-1220	inferior	_	
7-22	1221-1228	frontal	_	
7-23	1229-1234	gyrus	_	
7-24	1235-1236	(	_	
7-25	1236-1239	i.e	_	
7-26	1239-1240	.	_	
7-27	1241-1244	the	_	
7-28	1245-1249	most	_	
7-29	1250-1256	highly	_	
7-30	1257-1266	recruited	_	
7-31	1267-1271	area	_	
7-32	1272-1275	for	_	
7-33	1276-1279	the	_	
7-34	1280-1284	task	_	
7-35	1284-1285	)	_	
7-36	1286-1289	and	_	
7-37	1289-1290	:	_	
7-38	1291-1292	1	_	
7-39	1292-1293	)	_	
7-40	1294-1297	the	_	
7-41	1298-1302	left	_	
7-42	1303-1311	inferior	_	
7-43	1312-1319	frontal	_	
7-44	1320-1325	gyrus	_	
7-45	1325-1326	,	_	
7-46	1327-1330	and	_	
7-47	1331-1332	2	_	
7-48	1332-1333	)	_	
7-49	1334-1337	the	_	
7-50	1338-1342	left	_	
7-51	1343-1352	posterior	_	
7-52	1353-1362	cingulate	_	
7-53	1363-1368	gyrus	_	
7-54	1368-1369	,	_	
7-55	1370-1382	encompassing	_	
7-56	1383-1386	the	_	
7-57	1387-1396	precuneus	_	
7-58	1396-1397	;	_	
7-59	1398-1402	both	_	
7-60	1403-1405	as	_	
7-61	1406-1407	a	_	
7-62	1408-1412	main	_	
7-63	1413-1419	effect	_	
7-64	1420-1426	across	_	
7-65	1427-1435	controls	_	
7-66	1436-1439	and	_	
7-67	1440-1449	psychosis	_	
7-68	1450-1458	patients	_	
7-69	1458-1459	.	_	

#Text=Such association of the risk allele with reduced functional connectivity (with no area where the opposite main effect was detected), converges with findings in other tasks, our previous finding of its widespread impact on brain white matter microstructure, and with the dysconnectivity hypothesis of SCZ.
8-1	1460-1464	Such	_	
8-2	1465-1476	association	_	
8-3	1477-1479	of	_	
8-4	1480-1483	the	_	
8-5	1484-1488	risk	_	
8-6	1489-1495	allele	_	
8-7	1496-1500	with	_	
8-8	1501-1508	reduced	_	
8-9	1509-1519	functional	_	
8-10	1520-1532	connectivity	_	
8-11	1533-1534	(	_	
8-12	1534-1538	with	_	
8-13	1539-1541	no	_	
8-14	1542-1546	area	_	
8-15	1547-1552	where	_	
8-16	1553-1556	the	_	
8-17	1557-1565	opposite	_	
8-18	1566-1570	main	_	
8-19	1571-1577	effect	_	
8-20	1578-1581	was	_	
8-21	1582-1590	detected	_	
8-22	1590-1591	)	_	
8-23	1591-1592	,	_	
8-24	1593-1602	converges	_	
8-25	1603-1607	with	_	
8-26	1608-1616	findings	_	
8-27	1617-1619	in	_	
8-28	1620-1625	other	_	
8-29	1626-1631	tasks	_	
8-30	1631-1632	,	_	
8-31	1633-1636	our	_	
8-32	1637-1645	previous	_	
8-33	1646-1653	finding	_	
8-34	1654-1656	of	_	
8-35	1657-1660	its	_	
8-36	1661-1671	widespread	_	
8-37	1672-1678	impact	_	
8-38	1679-1681	on	_	
8-39	1682-1687	brain	_	
8-40	1688-1693	white	_	
8-41	1694-1700	matter	_	
8-42	1701-1715	microstructure	_	
8-43	1715-1716	,	_	
8-44	1717-1720	and	_	
8-45	1721-1725	with	_	
8-46	1726-1729	the	_	
8-47	1730-1745	dysconnectivity	_	
8-48	1746-1756	hypothesis	_	
8-49	1757-1759	of	_	
8-50	1760-1763	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
8-51	1763-1764	.	_	

#Text=Introduction
#Text=Schizophrenia (SCZ) and bipolar disorder (BD) have high heritability.
9-1	1765-1777	Introduction	_	
9-2	1778-1791	Schizophrenia	_	
9-3	1792-1793	(	_	
9-4	1793-1796	SCZ	_	
9-5	1796-1797	)	_	
9-6	1798-1801	and	_	
9-7	1802-1809	bipolar	_	
9-8	1810-1818	disorder	_	
9-9	1819-1820	(	_	
9-10	1820-1822	BD	_	
9-11	1822-1823	)	_	
9-12	1824-1828	have	_	
9-13	1829-1833	high	_	
9-14	1834-1846	heritability	_	
9-15	1846-1847	.	_	

#Text=Genome-wide association studies (GWAS) have robustly identified ZNF804A as a significant risk gene for both illnesses, by virtue of it containing the rs1344706 polymorphism for which the adenine (A) allele was slightly more common in both patient groups.
10-1	1848-1859	Genome-wide	_	
10-2	1860-1871	association	_	
10-3	1872-1879	studies	_	
10-4	1880-1881	(	_	
10-5	1881-1885	GWAS	_	
10-6	1885-1886	)	_	
10-7	1887-1891	have	_	
10-8	1892-1900	robustly	_	
10-9	1901-1911	identified	_	
10-10	1912-1919	ZNF804A	_	
10-11	1920-1922	as	_	
10-12	1923-1924	a	_	
10-13	1925-1936	significant	_	
10-14	1937-1941	risk	_	
10-15	1942-1946	gene	_	
10-16	1947-1950	for	_	
10-17	1951-1955	both	_	
10-18	1956-1965	illnesses	_	
10-19	1965-1966	,	_	
10-20	1967-1969	by	_	
10-21	1970-1976	virtue	_	
10-22	1977-1979	of	_	
10-23	1980-1982	it	_	
10-24	1983-1993	containing	_	
10-25	1994-1997	the	_	
10-26	1998-2007	rs1344706	_	
10-27	2008-2020	polymorphism	_	
10-28	2021-2024	for	_	
10-29	2025-2030	which	_	
10-30	2031-2034	the	_	
10-31	2035-2042	adenine	_	
10-32	2043-2044	(	_	
10-33	2044-2045	A	_	
10-34	2045-2046	)	_	
10-35	2047-2053	allele	_	
10-36	2054-2057	was	_	
10-37	2058-2066	slightly	_	
10-38	2067-2071	more	_	
10-39	2072-2078	common	_	
10-40	2079-2081	in	_	
10-41	2082-2086	both	_	
10-42	2087-2094	patient	_	
10-43	2095-2101	groups	_	
10-44	2101-2102	.	_	

#Text=A validation of this finding at the brain systems-level is imperative as there is still little understanding of how it heightens risk.
11-1	2103-2104	A	_	
11-2	2105-2115	validation	_	
11-3	2116-2118	of	_	
11-4	2119-2123	this	_	
11-5	2124-2131	finding	_	
11-6	2132-2134	at	_	
11-7	2135-2138	the	_	
11-8	2139-2144	brain	_	
11-9	2145-2158	systems-level	_	
11-10	2159-2161	is	_	
11-11	2162-2172	imperative	_	
11-12	2173-2175	as	_	
11-13	2176-2181	there	_	
11-14	2182-2184	is	_	
11-15	2185-2190	still	_	
11-16	2191-2197	little	_	
11-17	2198-2211	understanding	_	
11-18	2212-2214	of	_	
11-19	2215-2218	how	_	
11-20	2219-2221	it	_	
11-21	2222-2231	heightens	_	
11-22	2232-2236	risk	_	
11-23	2236-2237	.	_	

#Text=ZNF804A expresses the zinc-finger protein 804A with a domain typical of a transcription factor in the developing hippocampus, the cortex, and the adult cerebellum.
12-1	2238-2245	ZNF804A	_	
12-2	2246-2255	expresses	_	
12-3	2256-2259	the	_	
12-4	2260-2271	zinc-finger	_	
12-5	2272-2279	protein	_	
12-6	2280-2284	804A	_	
12-7	2285-2289	with	_	
12-8	2290-2291	a	_	
12-9	2292-2298	domain	_	
12-10	2299-2306	typical	_	
12-11	2307-2309	of	_	
12-12	2310-2311	a	_	
12-13	2312-2325	transcription	_	
12-14	2326-2332	factor	_	
12-15	2333-2335	in	_	
12-16	2336-2339	the	_	
12-17	2340-2350	developing	_	
12-18	2351-2362	hippocampus	_	
12-19	2362-2363	,	_	
12-20	2364-2367	the	_	
12-21	2368-2374	cortex	_	
12-22	2374-2375	,	_	
12-23	2376-2379	and	_	
12-24	2380-2383	the	_	
12-25	2384-2389	adult	_	
12-26	2390-2400	cerebellum	_	
12-27	2400-2401	.	_	

#Text=Consistent with a neurodevelopmental role, we recently found the risk allele (A) to be highly significantly associated with widespread decreased white matter microstructural fractional anisotropy (putatively a proxy of its integrity) across healthy subjects, as well as patients with SCZ and with BD - but particularly strongly in SCZ.
13-1	2402-2412	Consistent	_	
13-2	2413-2417	with	_	
13-3	2418-2419	a	_	
13-4	2420-2438	neurodevelopmental	_	
13-5	2439-2443	role	_	
13-6	2443-2444	,	_	
13-7	2445-2447	we	_	
13-8	2448-2456	recently	_	
13-9	2457-2462	found	_	
13-10	2463-2466	the	_	
13-11	2467-2471	risk	_	
13-12	2472-2478	allele	_	
13-13	2479-2480	(	_	
13-14	2480-2481	A	_	
13-15	2481-2482	)	_	
13-16	2483-2485	to	_	
13-17	2486-2488	be	_	
13-18	2489-2495	highly	_	
13-19	2496-2509	significantly	_	
13-20	2510-2520	associated	_	
13-21	2521-2525	with	_	
13-22	2526-2536	widespread	_	
13-23	2537-2546	decreased	_	
13-24	2547-2552	white	_	
13-25	2553-2559	matter	_	
13-26	2560-2575	microstructural	_	
13-27	2576-2586	fractional	_	
13-28	2587-2597	anisotropy	_	
13-29	2598-2599	(	_	
13-30	2599-2609	putatively	_	
13-31	2610-2611	a	_	
13-32	2612-2617	proxy	_	
13-33	2618-2620	of	_	
13-34	2621-2624	its	_	
13-35	2625-2634	integrity	_	
13-36	2634-2635	)	_	
13-37	2636-2642	across	_	
13-38	2643-2650	healthy	_	
13-39	2651-2659	subjects	_	
13-40	2659-2660	,	_	
13-41	2661-2663	as	_	
13-42	2664-2668	well	_	
13-43	2669-2671	as	_	
13-44	2672-2680	patients	_	
13-45	2681-2685	with	_	
13-46	2686-2689	SCZ	_	
13-47	2690-2693	and	_	
13-48	2694-2698	with	_	
13-49	2699-2701	BD	_	
13-50	2702-2703	-	_	
13-51	2704-2707	but	_	
13-52	2708-2720	particularly	_	
13-53	2721-2729	strongly	_	
13-54	2730-2732	in	_	
13-55	2733-2736	SCZ	_	
13-56	2736-2737	.	_	

#Text=We now asked whether it would, consequently, have a detrimental effect (and possibly larger in SCZ patients) on regional brain activation and functional connectivity during a type of cognitive processing which is, together with its neural correlates, affected in BD and SCZ, and their healthy relatives: verbal fluency.
14-1	2738-2740	We	_	
14-2	2741-2744	now	_	
14-3	2745-2750	asked	_	
14-4	2751-2758	whether	_	
14-5	2759-2761	it	_	
14-6	2762-2767	would	_	
14-7	2767-2768	,	_	
14-8	2769-2781	consequently	_	
14-9	2781-2782	,	_	
14-10	2783-2787	have	_	
14-11	2788-2789	a	_	
14-12	2790-2801	detrimental	_	
14-13	2802-2808	effect	_	
14-14	2809-2810	(	_	
14-15	2810-2813	and	_	
14-16	2814-2822	possibly	_	
14-17	2823-2829	larger	_	
14-18	2830-2832	in	_	
14-19	2833-2836	SCZ	_	
14-20	2837-2845	patients	_	
14-21	2845-2846	)	_	
14-22	2847-2849	on	_	
14-23	2850-2858	regional	_	
14-24	2859-2864	brain	_	
14-25	2865-2875	activation	_	
14-26	2876-2879	and	_	
14-27	2880-2890	functional	_	
14-28	2891-2903	connectivity	_	
14-29	2904-2910	during	_	
14-30	2911-2912	a	_	
14-31	2913-2917	type	_	
14-32	2918-2920	of	_	
14-33	2921-2930	cognitive	_	
14-34	2931-2941	processing	_	
14-35	2942-2947	which	_	
14-36	2948-2950	is	_	
14-37	2950-2951	,	_	
14-38	2952-2960	together	_	
14-39	2961-2965	with	_	
14-40	2966-2969	its	_	
14-41	2970-2976	neural	_	
14-42	2977-2987	correlates	_	
14-43	2987-2988	,	_	
14-44	2989-2997	affected	_	
14-45	2998-3000	in	_	
14-46	3001-3003	BD	_	
14-47	3004-3007	and	_	
14-48	3008-3011	SCZ	_	
14-49	3011-3012	,	_	
14-50	3013-3016	and	_	
14-51	3017-3022	their	_	
14-52	3023-3030	healthy	_	
14-53	3031-3040	relatives	_	
14-54	3040-3041	:	_	
14-55	3042-3048	verbal	_	
14-56	3049-3056	fluency	_	
14-57	3056-3057	.	_	

#Text=Such effect would be consistent with previous findings associating it with a decrease in functional connectivity during working memory.
15-1	3058-3062	Such	_	
15-2	3063-3069	effect	_	
15-3	3070-3075	would	_	
15-4	3076-3078	be	_	
15-5	3079-3089	consistent	_	
15-6	3090-3094	with	_	
15-7	3095-3103	previous	_	
15-8	3104-3112	findings	_	
15-9	3113-3124	associating	_	
15-10	3125-3127	it	_	
15-11	3128-3132	with	_	
15-12	3133-3134	a	_	
15-13	3135-3143	decrease	_	
15-14	3144-3146	in	_	
15-15	3147-3157	functional	_	
15-16	3158-3170	connectivity	_	
15-17	3171-3177	during	_	
15-18	3178-3185	working	_	
15-19	3186-3192	memory	_	
15-20	3192-3193	.	_	

#Text=On behaviour, effects seem smaller or less detectable, with one study showing a weak-to-modestly linked allele (in terms of linkage disequilibrium) to be marginally associated with better category fluency, but not verbal fluency, in healthy males; and the present risk allele with worse visuo-motor performance, but again not verbal fluency nor verbal learning.
16-1	3194-3196	On	_	
16-2	3197-3206	behaviour	_	
16-3	3206-3207	,	_	
16-4	3208-3215	effects	_	
16-5	3216-3220	seem	_	
16-6	3221-3228	smaller	_	
16-7	3229-3231	or	_	
16-8	3232-3236	less	_	
16-9	3237-3247	detectable	_	
16-10	3247-3248	,	_	
16-11	3249-3253	with	_	
16-12	3254-3257	one	_	
16-13	3258-3263	study	_	
16-14	3264-3271	showing	_	
16-15	3272-3273	a	_	
16-16	3274-3290	weak-to-modestly	_	
16-17	3291-3297	linked	_	
16-18	3298-3304	allele	_	
16-19	3305-3306	(	_	
16-20	3306-3308	in	_	
16-21	3309-3314	terms	_	
16-22	3315-3317	of	_	
16-23	3318-3325	linkage	_	
16-24	3326-3340	disequilibrium	_	
16-25	3340-3341	)	_	
16-26	3342-3344	to	_	
16-27	3345-3347	be	_	
16-28	3348-3358	marginally	_	
16-29	3359-3369	associated	_	
16-30	3370-3374	with	_	
16-31	3375-3381	better	_	
16-32	3382-3390	category	_	
16-33	3391-3398	fluency	_	
16-34	3398-3399	,	_	
16-35	3400-3403	but	_	
16-36	3404-3407	not	_	
16-37	3408-3414	verbal	_	
16-38	3415-3422	fluency	_	
16-39	3422-3423	,	_	
16-40	3424-3426	in	_	
16-41	3427-3434	healthy	_	
16-42	3435-3440	males	_	
16-43	3440-3441	;	_	
16-44	3442-3445	and	_	
16-45	3446-3449	the	_	
16-46	3450-3457	present	_	
16-47	3458-3462	risk	_	
16-48	3463-3469	allele	_	
16-49	3470-3474	with	_	
16-50	3475-3480	worse	_	
16-51	3481-3492	visuo-motor	_	
16-52	3493-3504	performance	_	
16-53	3504-3505	,	_	
16-54	3506-3509	but	_	
16-55	3510-3515	again	_	
16-56	3516-3519	not	_	
16-57	3520-3526	verbal	_	
16-58	3527-3534	fluency	_	
16-59	3535-3538	nor	_	
16-60	3539-3545	verbal	_	
16-61	3546-3554	learning	_	
16-62	3554-3555	.	_	

#Text=Material and methods
#Text=We genotyped (for ZNF804A rs1344706) and scanned, with functional MRI, 174 English native speakers [80 healthy volunteers without history of mental illness, 54 patients with SCZ and 40 with BD (75% of whom had a history of psychosis symptoms)], recruited from the SLAM NHS Trust and diagnosed according to DSM-IV (methodological detail and references are available in Supplement 1).
17-1	3556-3564	Material	http://www.case.edu/ProvCaRe/provcare#StudyMethod[5]	
17-2	3565-3568	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[5]	
17-3	3569-3576	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[5]	
17-4	3577-3579	We	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-5	3580-3589	genotyped	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-6	3590-3591	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-7	3591-3594	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-8	3595-3602	ZNF804A	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-9	3603-3612	rs1344706	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-10	3612-3613	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-11	3614-3617	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-12	3618-3625	scanned	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-13	3625-3626	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-14	3627-3631	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-15	3632-3642	functional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[7]	
17-16	3643-3646	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[7]	
17-17	3646-3647	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-18	3648-3651	174	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-19	3652-3659	English	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-20	3660-3666	native	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-21	3667-3675	speakers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-22	3676-3677	[	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-23	3677-3679	80	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-24	3680-3687	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
17-25	3688-3698	volunteers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
17-26	3699-3706	without	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-27	3707-3714	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-28	3715-3717	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-29	3718-3724	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-30	3725-3732	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-31	3732-3733	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-32	3734-3736	54	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-33	3737-3745	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-34	3746-3750	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-35	3751-3754	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]	
17-36	3755-3758	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-37	3759-3761	40	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-38	3762-3766	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-39	3767-3769	BD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[10]	
17-40	3770-3771	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-41	3771-3774	75%	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-42	3775-3777	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-43	3778-3782	whom	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-44	3783-3786	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-45	3787-3788	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-46	3789-3796	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-47	3797-3799	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-48	3800-3809	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-49	3810-3818	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-50	3818-3819	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-51	3819-3820	]	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-52	3820-3821	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-53	3822-3831	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-54	3832-3836	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-55	3837-3840	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-56	3841-3845	SLAM	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-57	3846-3849	NHS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-58	3850-3855	Trust	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-59	3856-3859	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-60	3860-3869	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-61	3870-3879	according	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-62	3880-3882	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-63	3883-3889	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-64	3890-3891	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-65	3891-3905	methodological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-66	3906-3912	detail	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-67	3913-3916	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-68	3917-3927	references	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-69	3928-3931	are	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-70	3932-3941	available	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-71	3942-3944	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-72	3945-3955	Supplement	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-73	3956-3957	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-74	3957-3958	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
17-75	3958-3959	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=This yielded 84 rs134470684 allele A homozygotes and 90 allele C carriers, and given the very low frequency of allele C in Caucasian population, we grouped the non-risk allele C homozygotes with the heterozygotes.
18-1	3960-3964	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-2	3965-3972	yielded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-3	3973-3975	84	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-4	3976-3987	rs134470684	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-5	3988-3994	allele	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-6	3995-3996	A	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-7	3997-4008	homozygotes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-8	4009-4012	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-9	4013-4015	90	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-10	4016-4022	allele	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-11	4023-4024	C	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-12	4025-4033	carriers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-13	4033-4034	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-14	4035-4038	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-15	4039-4044	given	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-16	4045-4048	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-17	4049-4053	very	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-18	4054-4057	low	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-19	4058-4067	frequency	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-20	4068-4070	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-21	4071-4077	allele	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-22	4078-4079	C	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-23	4080-4082	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-24	4083-4092	Caucasian	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-25	4093-4103	population	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-26	4103-4104	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-27	4105-4107	we	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-28	4108-4115	grouped	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-29	4116-4119	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-30	4120-4128	non-risk	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-31	4129-4135	allele	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-32	4136-4137	C	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-33	4138-4149	homozygotes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-34	4150-4154	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-35	4155-4158	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-36	4159-4172	heterozygotes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
18-37	4172-4173	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=The study was approved and reviewed by the National Health Service (NHS) South East London Research Ethics Committee, UK (Project “Genetics and Psychosis (GAP)” reference number 047/04) and was carried in accordance with the latest version of the Declaration of Helsinki.
19-1	4174-4177	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-2	4178-4183	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-3	4184-4187	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-4	4188-4196	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-5	4197-4200	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-6	4201-4209	reviewed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-7	4210-4212	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-8	4213-4216	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-9	4217-4225	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-10	4226-4232	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-11	4233-4240	Service	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-12	4241-4242	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-13	4242-4245	NHS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-14	4245-4246	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-15	4247-4252	South	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-16	4253-4257	East	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-17	4258-4264	London	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-18	4265-4273	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-19	4274-4280	Ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-20	4281-4290	Committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-21	4290-4291	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-22	4292-4294	UK	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-23	4295-4296	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-24	4296-4303	Project	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-25	4304-4305	“	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-26	4305-4313	Genetics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-27	4314-4317	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-28	4318-4327	Psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-29	4328-4329	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-30	4329-4332	GAP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-31	4332-4333	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-32	4333-4334	”	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-33	4335-4344	reference	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-34	4345-4351	number	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-35	4352-4355	047	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-36	4355-4356	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-37	4356-4358	04	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-38	4358-4359	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-39	4360-4363	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-40	4364-4367	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-41	4368-4375	carried	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-42	4376-4378	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-43	4379-4389	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-44	4390-4394	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-45	4395-4398	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-46	4399-4405	latest	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-47	4406-4413	version	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-48	4414-4416	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-49	4417-4420	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-50	4421-4432	Declaration	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-51	4433-4435	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-52	4436-4444	Helsinki	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
19-53	4444-4445	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=Informed consent of the participants was obtained after the nature of the procedures had been fully explained.
20-1	4446-4454	Informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-2	4455-4462	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-3	4463-4465	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-4	4466-4469	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-5	4470-4482	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-6	4483-4486	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-7	4487-4495	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-8	4496-4501	after	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-9	4502-4505	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-10	4506-4512	nature	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-11	4513-4515	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-12	4516-4519	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-13	4520-4530	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-14	4531-4534	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-15	4535-4539	been	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-16	4540-4545	fully	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-17	4546-4555	explained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
20-18	4555-4556	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=There were no demographic differences (at p < 0.05) between genotype or diagnostic groups, other than CPZ-equivalent medication and male:female being higher, and IQ lower, in patients with SCZ (see sample's demographics in Supplement 2).
21-1	4557-4562	There	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-2	4563-4567	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-3	4568-4570	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-4	4571-4582	demographic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-5	4583-4594	differences	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-6	4595-4596	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-7	4596-4598	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-8	4599-4600	p	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-9	4600-4601	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-10	4601-4602	<	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-11	4602-4603	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-12	4603-4607	0.05	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-13	4607-4608	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-14	4609-4616	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-15	4617-4625	genotype	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-16	4626-4628	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-17	4629-4639	diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-18	4640-4646	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-19	4646-4647	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-20	4648-4653	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-21	4654-4658	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-22	4659-4673	CPZ-equivalent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-23	4674-4684	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-24	4685-4688	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-25	4689-4693	male	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-26	4693-4694	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-27	4694-4700	female	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-28	4701-4706	being	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-29	4707-4713	higher	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-30	4713-4714	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-31	4715-4718	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-32	4719-4721	IQ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-33	4722-4727	lower	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-34	4727-4728	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-35	4729-4731	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-36	4732-4740	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-37	4741-4745	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-38	4746-4749	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[11]	
21-39	4750-4751	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-40	4751-4754	see	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-41	4755-4763	sample's	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-42	4764-4776	demographics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-43	4777-4779	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-44	4780-4790	Supplement	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-45	4791-4792	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-46	4792-4793	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
21-47	4793-4794	.	_	

#Text=The verbal fluency task [where subjects are required to overtly generate a word starting with a visually-displayed letter; or overtly read the word “rest” (control or repetition condition)], image acquisition, pre-processing and analysis using SPM software was performed as described earlier.
22-1	4795-4798	The	_	
22-2	4799-4805	verbal	_	
22-3	4806-4813	fluency	_	
22-4	4814-4818	task	_	
22-5	4819-4820	[	_	
22-6	4820-4825	where	_	
22-7	4826-4834	subjects	_	
22-8	4835-4838	are	_	
22-9	4839-4847	required	_	
22-10	4848-4850	to	_	
22-11	4851-4858	overtly	_	
22-12	4859-4867	generate	_	
22-13	4868-4869	a	_	
22-14	4870-4874	word	_	
22-15	4875-4883	starting	_	
22-16	4884-4888	with	_	
22-17	4889-4890	a	_	
22-18	4891-4909	visually-displayed	_	
22-19	4910-4916	letter	_	
22-20	4916-4917	;	_	
22-21	4918-4920	or	_	
22-22	4921-4928	overtly	_	
22-23	4929-4933	read	_	
22-24	4934-4937	the	_	
22-25	4938-4942	word	_	
22-26	4943-4944	“	_	
22-27	4944-4948	rest	_	
22-28	4948-4949	”	_	
22-29	4950-4951	(	_	
22-30	4951-4958	control	_	
22-31	4959-4961	or	_	
22-32	4962-4972	repetition	_	
22-33	4973-4982	condition	_	
22-34	4982-4983	)	_	
22-35	4983-4984	]	_	
22-36	4984-4985	,	_	
22-37	4986-4991	image	_	
22-38	4992-5003	acquisition	_	
22-39	5003-5004	,	_	
22-40	5005-5019	pre-processing	_	
22-41	5020-5023	and	_	
22-42	5024-5032	analysis	_	
22-43	5033-5038	using	_	
22-44	5039-5042	SPM	_	
22-45	5043-5051	software	_	
22-46	5052-5055	was	_	
22-47	5056-5065	performed	_	
22-48	5066-5068	as	_	
22-49	5069-5078	described	_	
22-50	5079-5086	earlier	_	
22-51	5086-5087	.	_	

#Text=A multifactorial ANOVA was used to test for the main effect of genotype (A homozygotes vs.
23-1	5088-5089	A	_	
23-2	5090-5104	multifactorial	_	
23-3	5105-5110	ANOVA	_	
23-4	5111-5114	was	_	
23-5	5115-5119	used	_	
23-6	5120-5122	to	_	
23-7	5123-5127	test	_	
23-8	5128-5131	for	_	
23-9	5132-5135	the	_	
23-10	5136-5140	main	_	
23-11	5141-5147	effect	_	
23-12	5148-5150	of	_	
23-13	5151-5159	genotype	_	
23-14	5160-5161	(	_	
23-15	5161-5162	A	_	
23-16	5163-5174	homozygotes	_	
23-17	5175-5177	vs	_	
23-18	5177-5178	.	_	

#Text=C carriers) and its interaction with diagnosis (controls vs.
24-1	5179-5180	C	_	
24-2	5181-5189	carriers	_	
24-3	5189-5190	)	_	
24-4	5191-5194	and	_	
24-5	5195-5198	its	_	
24-6	5199-5210	interaction	_	
24-7	5211-5215	with	_	
24-8	5216-5225	diagnosis	_	
24-9	5226-5227	(	_	
24-10	5227-5235	controls	_	
24-11	5236-5238	vs	_	
24-12	5238-5239	.	_	

#Text=BD vs.
25-1	5240-5242	BD	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder	
25-2	5243-5245	vs	_	
25-3	5245-5246	.	_	

#Text=SCZ; or all psychosis patients, i.e. 100% of SCZ group + 75% of BD group, vs. controls).
26-1	5247-5250	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
26-2	5250-5251	;	_	
26-3	5252-5254	or	_	
26-4	5255-5258	all	_	
26-5	5259-5268	psychosis	_	
26-6	5269-5277	patients	_	
26-7	5277-5278	,	_	
26-8	5279-5282	i.e	_	
26-9	5282-5283	.	_	
26-10	5284-5288	100%	_	
26-11	5289-5291	of	_	
26-12	5292-5295	SCZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
26-13	5296-5301	group	_	
26-14	5301-5302	 	_	
26-15	5302-5303	+	_	
26-16	5303-5304	 	_	
26-17	5304-5307	75%	_	
26-18	5308-5310	of	_	
26-19	5311-5313	BD	http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder	
26-20	5314-5319	group	_	
26-21	5319-5320	,	_	
26-22	5321-5323	vs	_	
26-23	5323-5324	.	_	
26-24	5325-5333	controls	_	
26-25	5333-5334	)	_	
26-26	5334-5335	.	_	

#Text=These effects were tested on whole-brain regional activation and on functional connectivity, including connectivity that would depend on task trials (i.e. psychophysiological interaction; PPI).
27-1	5336-5341	These	_	
27-2	5342-5349	effects	_	
27-3	5350-5354	were	_	
27-4	5355-5361	tested	_	
27-5	5362-5364	on	_	
27-6	5365-5376	whole-brain	_	
27-7	5377-5385	regional	_	
27-8	5386-5396	activation	_	
27-9	5397-5400	and	_	
27-10	5401-5403	on	_	
27-11	5404-5414	functional	_	
27-12	5415-5427	connectivity	_	
27-13	5427-5428	,	_	
27-14	5429-5438	including	_	
27-15	5439-5451	connectivity	_	
27-16	5452-5456	that	_	
27-17	5457-5462	would	_	
27-18	5463-5469	depend	_	
27-19	5470-5472	on	_	
27-20	5473-5477	task	_	
27-21	5478-5484	trials	_	
27-22	5485-5486	(	_	
27-23	5486-5489	i.e	_	
27-24	5489-5490	.	_	
27-25	5491-5510	psychophysiological	_	
27-26	5511-5522	interaction	_	
27-27	5522-5523	;	_	
27-28	5524-5527	PPI	_	
27-29	5527-5528	)	_	
27-30	5528-5529	.	_	

#Text=Main effect of task is reported for completeness, but not discussed, as it has already been described in a highly overlapping sample.
28-1	5530-5534	Main	_	
28-2	5535-5541	effect	_	
28-3	5542-5544	of	_	
28-4	5545-5549	task	_	
28-5	5550-5552	is	_	
28-6	5553-5561	reported	_	
28-7	5562-5565	for	_	
28-8	5566-5578	completeness	_	
28-9	5578-5579	,	_	
28-10	5580-5583	but	_	
28-11	5584-5587	not	_	
28-12	5588-5597	discussed	_	
28-13	5597-5598	,	_	
28-14	5599-5601	as	_	
28-15	5602-5604	it	_	
28-16	5605-5608	has	_	
28-17	5609-5616	already	_	
28-18	5617-5621	been	_	
28-19	5622-5631	described	_	
28-20	5632-5634	in	_	
28-21	5635-5636	a	_	
28-22	5637-5643	highly	_	
28-23	5644-5655	overlapping	_	
28-24	5656-5662	sample	_	
28-25	5662-5663	.	_	

#Text=Incorrect response trials were excluded to avoid confounding effects of task performance.
29-1	5664-5673	Incorrect	_	
29-2	5674-5682	response	_	
29-3	5683-5689	trials	_	
29-4	5690-5694	were	_	
29-5	5695-5703	excluded	_	
29-6	5704-5706	to	_	
29-7	5707-5712	avoid	_	
29-8	5713-5724	confounding	_	
29-9	5725-5732	effects	_	
29-10	5733-5735	of	_	
29-11	5736-5740	task	_	
29-12	5741-5752	performance	_	
29-13	5752-5753	.	_	

#Text=For connectivity, we used, as seed, the 6-mm radius sphere where the main effect of task was the highest (i.e. left precentral gyrus/inferior frontal gyrus, pars opercularis: −44 4 34). ηp2 measures of effect size were calculated in R to assess how much of the inter-individual (+error) variance in peak activation was explained by genotype.
30-1	5754-5757	For	_	
30-2	5758-5770	connectivity	_	
30-3	5770-5771	,	_	
30-4	5772-5774	we	_	
30-5	5775-5779	used	_	
30-6	5779-5780	,	_	
30-7	5781-5783	as	_	
30-8	5784-5788	seed	_	
30-9	5788-5789	,	_	
30-10	5790-5793	the	_	
30-11	5794-5795	6	_	
30-12	5795-5796	-	_	
30-13	5796-5798	mm	_	
30-14	5799-5805	radius	_	
30-15	5806-5812	sphere	_	
30-16	5813-5818	where	_	
30-17	5819-5822	the	_	
30-18	5823-5827	main	_	
30-19	5828-5834	effect	_	
30-20	5835-5837	of	_	
30-21	5838-5842	task	_	
30-22	5843-5846	was	_	
30-23	5847-5850	the	_	
30-24	5851-5858	highest	_	
30-25	5859-5860	(	_	
30-26	5860-5863	i.e	_	
30-27	5863-5864	.	_	
30-28	5865-5869	left	_	
30-29	5870-5880	precentral	_	
30-30	5881-5886	gyrus	_	
30-31	5886-5887	/	_	
30-32	5887-5895	inferior	_	
30-33	5896-5903	frontal	_	
30-34	5904-5909	gyrus	_	
30-35	5909-5910	,	_	
30-36	5911-5915	pars	_	
30-37	5916-5927	opercularis	_	
30-38	5927-5928	:	_	
30-39	5929-5930	−	_	
30-40	5930-5932	44	_	
30-41	5933-5934	4	_	
30-42	5935-5937	34	_	
30-43	5937-5938	)	_	
30-44	5938-5939	.	_	
30-45	5940-5943	ηp2	_	
30-46	5944-5952	measures	_	
30-47	5953-5955	of	_	
30-48	5956-5962	effect	_	
30-49	5963-5967	size	_	
30-50	5968-5972	were	_	
30-51	5973-5983	calculated	_	
30-52	5984-5986	in	_	
30-53	5987-5988	R	_	
30-54	5989-5991	to	_	
30-55	5992-5998	assess	_	
30-56	5999-6002	how	_	
30-57	6003-6007	much	_	
30-58	6008-6010	of	_	
30-59	6011-6014	the	_	
30-60	6015-6031	inter-individual	_	
30-61	6032-6033	(	_	
30-62	6033-6034	+	_	
30-63	6034-6039	error	_	
30-64	6039-6040	)	_	
30-65	6041-6049	variance	_	
30-66	6050-6052	in	_	
30-67	6053-6057	peak	_	
30-68	6058-6068	activation	_	
30-69	6069-6072	was	_	
30-70	6073-6082	explained	_	
30-71	6083-6085	by	_	
30-72	6086-6094	genotype	_	
30-73	6094-6095	.	_	

#Text=Results and discussion
#Text=Effect of verbal fluency on regional activation
#Text=Consistently with our previous findings with overlapping samples, word generation (irrespective of task difficulty) was associated (whole-brain, voxel-wise FWE-corrected <0.05) with activation in an extended network that included the left inferior and middle frontal gyrus, middle and posterior cingulate gyrus, as well as the anterior cerebellum (see Supplementary Table 2 for further detail).
31-1	6096-6103	Results	_	
31-2	6104-6107	and	_	
31-3	6108-6118	discussion	_	
31-4	6119-6125	Effect	_	
31-5	6126-6128	of	_	
31-6	6129-6135	verbal	_	
31-7	6136-6143	fluency	_	
31-8	6144-6146	on	_	
31-9	6147-6155	regional	_	
31-10	6156-6166	activation	_	
31-11	6167-6179	Consistently	_	
31-12	6180-6184	with	_	
31-13	6185-6188	our	_	
31-14	6189-6197	previous	_	
31-15	6198-6206	findings	_	
31-16	6207-6211	with	_	
31-17	6212-6223	overlapping	_	
31-18	6224-6231	samples	_	
31-19	6231-6232	,	_	
31-20	6233-6237	word	_	
31-21	6238-6248	generation	_	
31-22	6249-6250	(	_	
31-23	6250-6262	irrespective	_	
31-24	6263-6265	of	_	
31-25	6266-6270	task	_	
31-26	6271-6281	difficulty	_	
31-27	6281-6282	)	_	
31-28	6283-6286	was	_	
31-29	6287-6297	associated	_	
31-30	6298-6299	(	_	
31-31	6299-6310	whole-brain	_	
31-32	6310-6311	,	_	
31-33	6312-6322	voxel-wise	_	
31-34	6323-6336	FWE-corrected	_	
31-35	6337-6338	<	_	
31-36	6338-6342	0.05	_	
31-37	6342-6343	)	_	
31-38	6344-6348	with	_	
31-39	6349-6359	activation	_	
31-40	6360-6362	in	_	
31-41	6363-6365	an	_	
31-42	6366-6374	extended	_	
31-43	6375-6382	network	_	
31-44	6383-6387	that	_	
31-45	6388-6396	included	_	
31-46	6397-6400	the	_	
31-47	6401-6405	left	_	
31-48	6406-6414	inferior	_	
31-49	6415-6418	and	_	
31-50	6419-6425	middle	_	
31-51	6426-6433	frontal	_	
31-52	6434-6439	gyrus	_	
31-53	6439-6440	,	_	
31-54	6441-6447	middle	_	
31-55	6448-6451	and	_	
31-56	6452-6461	posterior	_	
31-57	6462-6471	cingulate	_	
31-58	6472-6477	gyrus	_	
31-59	6477-6478	,	_	
31-60	6479-6481	as	_	
31-61	6482-6486	well	_	
31-62	6487-6489	as	_	
31-63	6490-6493	the	_	
31-64	6494-6502	anterior	_	
31-65	6503-6513	cerebellum	_	
31-66	6514-6515	(	_	
31-67	6515-6518	see	_	
31-68	6519-6532	Supplementary	_	
31-69	6533-6538	Table	_	
31-70	6539-6540	2	_	
31-71	6541-6544	for	_	
31-72	6545-6552	further	_	
31-73	6553-6559	detail	_	
31-74	6559-6560	)	_	
31-75	6560-6561	.	_	

#Text=Conversely, repetition was associated with activation bilaterally in the angular gyrus, anterior cingulate and middle occipital gyri, and rolandic operculum.
32-1	6562-6572	Conversely	_	
32-2	6572-6573	,	_	
32-3	6574-6584	repetition	_	
32-4	6585-6588	was	_	
32-5	6589-6599	associated	_	
32-6	6600-6604	with	_	
32-7	6605-6615	activation	_	
32-8	6616-6627	bilaterally	_	
32-9	6628-6630	in	_	
32-10	6631-6634	the	_	
32-11	6635-6642	angular	_	
32-12	6643-6648	gyrus	_	
32-13	6648-6649	,	_	
32-14	6650-6658	anterior	_	
32-15	6659-6668	cingulate	_	
32-16	6669-6672	and	_	
32-17	6673-6679	middle	_	
32-18	6680-6689	occipital	_	
32-19	6690-6694	gyri	_	
32-20	6694-6695	,	_	
32-21	6696-6699	and	_	
32-22	6700-6708	rolandic	_	
32-23	6709-6718	operculum	_	
32-24	6718-6719	.	_	

#Text=Effect of ZNF804A rs1344706 on regional activation
#Text=– Part A: Genotype-by-diagnosis interaction in the left inferior frontal gyrus, pars triangularis/opercularis, where risk allele adenine (A) [vs.
33-1	6720-6726	Effect	_	
33-2	6727-6729	of	_	
33-3	6730-6737	ZNF804A	_	
33-4	6738-6747	rs1344706	_	
33-5	6748-6750	on	_	
33-6	6751-6759	regional	_	
33-7	6760-6770	activation	_	
33-8	6771-6772	–	_	
33-9	6773-6777	Part	_	
33-10	6778-6779	A	_	
33-11	6779-6780	:	_	
33-12	6781-6802	Genotype-by-diagnosis	_	
33-13	6803-6814	interaction	_	
33-14	6815-6817	in	_	
33-15	6818-6821	the	_	
33-16	6822-6826	left	_	
33-17	6827-6835	inferior	_	
33-18	6836-6843	frontal	_	
33-19	6844-6849	gyrus	_	
33-20	6849-6850	,	_	
33-21	6851-6855	pars	_	
33-22	6856-6868	triangularis	_	
33-23	6868-6869	/	_	
33-24	6869-6880	opercularis	_	
33-25	6880-6881	,	_	
33-26	6882-6887	where	_	
33-27	6888-6892	risk	_	
33-28	6893-6899	allele	_	
33-29	6900-6907	adenine	_	
33-30	6908-6909	(	_	
33-31	6909-6910	A	_	
33-32	6910-6911	)	_	
33-33	6912-6913	[	_	
33-34	6913-6915	vs	_	
33-35	6915-6916	.	_	

#Text=Cytosine (C) carriers] was associated with higher regional activation (Y-axis) in BD, but the reverse was seen in healthy volunteers (X-axis).
34-1	6917-6925	Cytosine	_	
34-2	6926-6927	(	_	
34-3	6927-6928	C	_	
34-4	6928-6929	)	_	
34-5	6930-6938	carriers	_	
34-6	6938-6939	]	_	
34-7	6940-6943	was	_	
34-8	6944-6954	associated	_	
34-9	6955-6959	with	_	
34-10	6960-6966	higher	_	
34-11	6967-6975	regional	_	
34-12	6976-6986	activation	_	
34-13	6987-6988	(	_	
34-14	6988-6994	Y-axis	_	
34-15	6994-6995	)	_	
34-16	6996-6998	in	_	
34-17	6999-7001	BD	_	
34-18	7001-7002	,	_	
34-19	7003-7006	but	_	
34-20	7007-7010	the	_	
34-21	7011-7018	reverse	_	
34-22	7019-7022	was	_	
34-23	7023-7027	seen	_	
34-24	7028-7030	in	_	
34-25	7031-7038	healthy	_	
34-26	7039-7049	volunteers	_	
34-27	7050-7051	(	_	
34-28	7051-7057	X-axis	_	
34-29	7057-7058	)	_	
34-30	7058-7059	.	_	

#Text=Part B: Main effect of ZNF804A rs1344706 genotype on functional connectivity, whereby risk allele A homozygotes [vs.
35-1	7060-7064	Part	_	
35-2	7065-7066	B	_	
35-3	7066-7067	:	_	
35-4	7068-7072	Main	_	
35-5	7073-7079	effect	_	
35-6	7080-7082	of	_	
35-7	7083-7090	ZNF804A	_	
35-8	7091-7100	rs1344706	_	
35-9	7101-7109	genotype	_	
35-10	7110-7112	on	_	
35-11	7113-7123	functional	_	
35-12	7124-7136	connectivity	_	
35-13	7136-7137	,	_	
35-14	7138-7145	whereby	_	
35-15	7146-7150	risk	_	
35-16	7151-7157	allele	_	
35-17	7158-7159	A	_	
35-18	7160-7171	homozygotes	_	
35-19	7172-7173	[	_	
35-20	7173-7175	vs	_	
35-21	7175-7176	.	_	

#Text=Cytosine (C) carriers] showed decreased connectivity between the left precentral gyrus/inferior frontal gyrus, pars opercularis (seed) and the left inferior frontal gyrus, pars triangularis/opercularis (Y-axis), across controls and patients with history of psychosis (i.e. the whole SCZ and 75% of the BD group; X-axis).
36-1	7177-7185	Cytosine	_	
36-2	7186-7187	(	_	
36-3	7187-7188	C	_	
36-4	7188-7189	)	_	
36-5	7190-7198	carriers	_	
36-6	7198-7199	]	_	
36-7	7200-7206	showed	_	
36-8	7207-7216	decreased	_	
36-9	7217-7229	connectivity	_	
36-10	7230-7237	between	_	
36-11	7238-7241	the	_	
36-12	7242-7246	left	_	
36-13	7247-7257	precentral	_	
36-14	7258-7263	gyrus	_	
36-15	7263-7264	/	_	
36-16	7264-7272	inferior	_	
36-17	7273-7280	frontal	_	
36-18	7281-7286	gyrus	_	
36-19	7286-7287	,	_	
36-20	7288-7292	pars	_	
36-21	7293-7304	opercularis	_	
36-22	7305-7306	(	_	
36-23	7306-7310	seed	_	
36-24	7310-7311	)	_	
36-25	7312-7315	and	_	
36-26	7316-7319	the	_	
36-27	7320-7324	left	_	
36-28	7325-7333	inferior	_	
36-29	7334-7341	frontal	_	
36-30	7342-7347	gyrus	_	
36-31	7347-7348	,	_	
36-32	7349-7353	pars	_	
36-33	7354-7366	triangularis	_	
36-34	7366-7367	/	_	
36-35	7367-7378	opercularis	_	
36-36	7379-7380	(	_	
36-37	7380-7386	Y-axis	_	
36-38	7386-7387	)	_	
36-39	7387-7388	,	_	
36-40	7389-7395	across	_	
36-41	7396-7404	controls	_	
36-42	7405-7408	and	_	
36-43	7409-7417	patients	_	
36-44	7418-7422	with	_	
36-45	7423-7430	history	_	
36-46	7431-7433	of	_	
36-47	7434-7443	psychosis	_	
36-48	7444-7445	(	_	
36-49	7445-7448	i.e	_	
36-50	7448-7449	.	_	
36-51	7450-7453	the	_	
36-52	7454-7459	whole	_	
36-53	7460-7463	SCZ	_	
36-54	7464-7467	and	_	
36-55	7468-7471	75%	_	
36-56	7472-7474	of	_	
36-57	7475-7478	the	_	
36-58	7479-7481	BD	_	
36-59	7482-7487	group	_	
36-60	7487-7488	;	_	
36-61	7489-7495	X-axis	_	
36-62	7495-7496	)	_	
36-63	7496-7497	.	_	

#Text=Regions are represented when surviving p < 0.001 uncorrected (see Table 1).
37-1	7498-7505	Regions	_	
37-2	7506-7509	are	_	
37-3	7510-7521	represented	_	
37-4	7522-7526	when	_	
37-5	7527-7536	surviving	_	
37-6	7537-7538	p	_	
37-7	7538-7539	 	_	
37-8	7539-7540	<	_	
37-9	7540-7541	 	_	
37-10	7541-7546	0.001	_	
37-11	7547-7558	uncorrected	_	
37-12	7559-7560	(	_	
37-13	7560-7563	see	_	
37-14	7564-7569	Table	_	
37-15	7570-7571	1	_	
37-16	7571-7572	)	_	
37-17	7572-7573	.	_	

#Text=Parameter estimates are for verbal fluency > repetition in the left inferior frontal gyrus, pars triangularis/opercularis (Part A: −48 14 10, z-score = 4.39, voxel-wise FWE-corrected p-value = 0.03; Part B: −28 26 22, z-score = 4.42, voxel-wise FWE-corrected p-value = 0.02; between-subjects SEM bars are in red).
38-1	7574-7583	Parameter	_	
38-2	7584-7593	estimates	_	
38-3	7594-7597	are	_	
38-4	7598-7601	for	_	
38-5	7602-7608	verbal	_	
38-6	7609-7616	fluency	_	
38-7	7616-7617	 	_	
38-8	7617-7618	>	_	
38-9	7618-7619	 	_	
38-10	7619-7629	repetition	_	
38-11	7630-7632	in	_	
38-12	7633-7636	the	_	
38-13	7637-7641	left	_	
38-14	7642-7650	inferior	_	
38-15	7651-7658	frontal	_	
38-16	7659-7664	gyrus	_	
38-17	7664-7665	,	_	
38-18	7666-7670	pars	_	
38-19	7671-7683	triangularis	_	
38-20	7683-7684	/	_	
38-21	7684-7695	opercularis	_	
38-22	7696-7697	(	_	
38-23	7697-7701	Part	_	
38-24	7702-7703	A	_	
38-25	7703-7704	:	_	
38-26	7705-7706	−	_	
38-27	7706-7708	48	_	
38-28	7709-7711	14	_	
38-29	7712-7714	10	_	
38-30	7714-7715	,	_	
38-31	7716-7723	z-score	_	
38-32	7723-7724	 	_	
38-33	7724-7725	=	_	
38-34	7725-7726	 	_	
38-35	7726-7730	4.39	_	
38-36	7730-7731	,	_	
38-37	7732-7742	voxel-wise	_	
38-38	7743-7756	FWE-corrected	_	
38-39	7757-7764	p-value	_	
38-40	7764-7765	 	_	
38-41	7765-7766	=	_	
38-42	7766-7767	 	_	
38-43	7767-7771	0.03	_	
38-44	7771-7772	;	_	
38-45	7773-7777	Part	_	
38-46	7778-7779	B	_	
38-47	7779-7780	:	_	
38-48	7781-7782	−	_	
38-49	7782-7784	28	_	
38-50	7785-7787	26	_	
38-51	7788-7790	22	_	
38-52	7790-7791	,	_	
38-53	7792-7799	z-score	_	
38-54	7799-7800	 	_	
38-55	7800-7801	=	_	
38-56	7801-7802	 	_	
38-57	7802-7806	4.42	_	
38-58	7806-7807	,	_	
38-59	7808-7818	voxel-wise	_	
38-60	7819-7832	FWE-corrected	_	
38-61	7833-7840	p-value	_	
38-62	7840-7841	 	_	
38-63	7841-7842	=	_	
38-64	7842-7843	 	_	
38-65	7843-7847	0.02	_	
38-66	7847-7848	;	_	
38-67	7849-7865	between-subjects	_	
38-68	7866-7869	SEM	_	
38-69	7870-7874	bars	_	
38-70	7875-7878	are	_	
38-71	7879-7881	in	_	
38-72	7882-7885	red	_	
38-73	7885-7886	)	_	
38-74	7886-7887	.	_	

#Text=Brain regions are labelled using an automatic-labelling atlas(∗) and confirmatory visual inspection of a manual book atlas(∗∗). (*) Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., Joliot, M., 2002.
39-1	7888-7893	Brain	_	
39-2	7894-7901	regions	_	
39-3	7902-7905	are	_	
39-4	7906-7914	labelled	_	
39-5	7915-7920	using	_	
39-6	7921-7923	an	_	
39-7	7924-7943	automatic-labelling	_	
39-8	7944-7949	atlas	_	
39-9	7949-7950	(	_	
39-10	7950-7951	∗	_	
39-11	7951-7952	)	_	
39-12	7953-7956	and	_	
39-13	7957-7969	confirmatory	_	
39-14	7970-7976	visual	_	
39-15	7977-7987	inspection	_	
39-16	7988-7990	of	_	
39-17	7991-7992	a	_	
39-18	7993-7999	manual	_	
39-19	8000-8004	book	_	
39-20	8005-8010	atlas	_	
39-21	8010-8011	(	_	
39-22	8011-8012	∗	_	
39-23	8012-8013	∗	_	
39-24	8013-8014	)	_	
39-25	8014-8015	.	_	
39-26	8016-8017	(	_	
39-27	8017-8018	*	_	
39-28	8018-8019	)	_	
39-29	8020-8035	Tzourio-Mazoyer	_	
39-30	8035-8036	,	_	
39-31	8037-8038	N	_	
39-32	8038-8039	.	_	
39-33	8039-8040	,	_	
39-34	8041-8048	Landeau	_	
39-35	8048-8049	,	_	
39-36	8050-8051	B	_	
39-37	8051-8052	.	_	
39-38	8052-8053	,	_	
39-39	8054-8068	Papathanassiou	_	
39-40	8068-8069	,	_	
39-41	8070-8071	D	_	
39-42	8071-8072	.	_	
39-43	8072-8073	,	_	
39-44	8074-8082	Crivello	_	
39-45	8082-8083	,	_	
39-46	8084-8085	F	_	
39-47	8085-8086	.	_	
39-48	8086-8087	,	_	
39-49	8088-8093	Etard	_	
39-50	8093-8094	,	_	
39-51	8095-8096	O	_	
39-52	8096-8097	.	_	
39-53	8097-8098	,	_	
39-54	8099-8107	Delcroix	_	
39-55	8107-8108	,	_	
39-56	8109-8110	N	_	
39-57	8110-8111	.	_	
39-58	8111-8112	,	_	
39-59	8113-8120	Mazoyer	_	
39-60	8120-8121	,	_	
39-61	8122-8123	B	_	
39-62	8123-8124	.	_	
39-63	8124-8125	,	_	
39-64	8126-8132	Joliot	_	
39-65	8132-8133	,	_	
39-66	8134-8135	M	_	
39-67	8135-8136	.	_	
39-68	8136-8137	,	_	
39-69	8138-8142	2002	_	
39-70	8142-8143	.	_	

#Text=Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain.
40-1	8144-8153	Automated	_	
40-2	8154-8164	Anatomical	_	
40-3	8165-8173	Labeling	_	
40-4	8174-8176	of	_	
40-5	8177-8188	Activations	_	
40-6	8189-8191	in	_	
40-7	8192-8195	SPM	_	
40-8	8196-8201	Using	_	
40-9	8202-8203	a	_	
40-10	8204-8215	Macroscopic	_	
40-11	8216-8226	Anatomical	_	
40-12	8227-8239	Parcellation	_	
40-13	8240-8242	of	_	
40-14	8243-8246	the	_	
40-15	8247-8250	MNI	_	
40-16	8251-8254	MRI	_	
40-17	8255-8269	Single-Subject	_	
40-18	8270-8275	Brain	_	
40-19	8275-8276	.	_	

#Text=NeuroImage 15, 273–289. https://doi.org/10.1006/nimg.2001.0978. (**) K.
41-1	8277-8287	NeuroImage	_	
41-2	8288-8290	15	_	
41-3	8290-8291	,	_	
41-4	8292-8295	273	_	
41-5	8295-8296	–	_	
41-6	8296-8299	289	_	
41-7	8299-8300	.	_	
41-8	8301-8306	https	_	
41-9	8306-8307	:	_	
41-10	8307-8308	/	_	
41-11	8308-8309	/	_	
41-12	8309-8316	doi.org	_	
41-13	8316-8317	/	_	
41-14	8317-8324	10.1006	_	
41-15	8324-8325	/	_	
41-16	8325-8329	nimg	_	
41-17	8329-8339	.2001.0978	_	
41-18	8339-8340	.	_	
41-19	8341-8342	(	_	
41-20	8342-8343	*	_	
41-21	8343-8344	*	_	
41-22	8344-8345	)	_	
41-23	8346-8347	K	_	
41-24	8347-8348	.	_	

#Text=Mai, J., Paxinos, G., Voss, T., 2008.
42-1	8349-8352	Mai	_	
42-2	8352-8353	,	_	
42-3	8354-8355	J	_	
42-4	8355-8356	.	_	
42-5	8356-8357	,	_	
42-6	8358-8365	Paxinos	_	
42-7	8365-8366	,	_	
42-8	8367-8368	G	_	
42-9	8368-8369	.	_	
42-10	8369-8370	,	_	
42-11	8371-8375	Voss	_	
42-12	8375-8376	,	_	
42-13	8377-8378	T	_	
42-14	8378-8379	.	_	
42-15	8379-8380	,	_	
42-16	8381-8385	2008	_	
42-17	8385-8386	.	_	

#Text=Atlas of the Human Brain, 3rd Edition, 3rd ed.
43-1	8387-8392	Atlas	_	
43-2	8393-8395	of	_	
43-3	8396-8399	the	_	
43-4	8400-8405	Human	_	
43-5	8406-8411	Brain	_	
43-6	8411-8412	,	_	
43-7	8413-8416	3rd	_	
43-8	8417-8424	Edition	_	
43-9	8424-8425	,	_	
43-10	8426-8429	3rd	_	
43-11	8430-8432	ed	_	
43-12	8432-8433	.	_	

#Text=Academic Press, San Diego.
44-1	8434-8442	Academic	_	
44-2	8443-8448	Press	_	
44-3	8448-8449	,	_	
44-4	8450-8453	San	_	
44-5	8454-8459	Diego	_	
44-6	8459-8460	.	_	

#Text=(For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
45-1	8461-8462	(	_	
45-2	8462-8465	For	_	
45-3	8466-8480	interpretation	_	
45-4	8481-8483	of	_	
45-5	8484-8487	the	_	
45-6	8488-8498	references	_	
45-7	8499-8501	to	_	
45-8	8502-8508	colour	_	
45-9	8509-8511	in	_	
45-10	8512-8516	this	_	
45-11	8517-8523	figure	_	
45-12	8524-8530	legend	_	
45-13	8530-8531	,	_	
45-14	8532-8535	the	_	
45-15	8536-8542	reader	_	
45-16	8543-8545	is	_	
45-17	8546-8554	referred	_	
45-18	8555-8557	to	_	
45-19	8558-8561	the	_	
45-20	8562-8565	Web	_	
45-21	8566-8573	version	_	
45-22	8574-8576	of	_	
45-23	8577-8581	this	_	
45-24	8582-8589	article	_	
45-25	8589-8590	.	_	
45-26	8590-8591	)	_	

#Text=Fig. 1
#Text=We found a genotype-by-diagnosis interaction in the left inferior frontal gyrus, pars opercularis/triangularis [Z = 4.39; whole-brain, voxel-wise FWE-corrected p = 0.03; ηp2 (peak) = 4.32%; Fig. 1 - Part A], where risk allele A was associated with higher regional activation in BD, but the reverse was seen in healthy volunteers.
46-1	8592-8595	Fig	_	
46-2	8595-8596	.	_	
46-3	8597-8598	1	_	
46-4	8599-8601	We	_	
46-5	8602-8607	found	_	
46-6	8608-8609	a	_	
46-7	8610-8631	genotype-by-diagnosis	_	
46-8	8632-8643	interaction	_	
46-9	8644-8646	in	_	
46-10	8647-8650	the	_	
46-11	8651-8655	left	_	
46-12	8656-8664	inferior	_	
46-13	8665-8672	frontal	_	
46-14	8673-8678	gyrus	_	
46-15	8678-8679	,	_	
46-16	8680-8684	pars	_	
46-17	8685-8696	opercularis	_	
46-18	8696-8697	/	_	
46-19	8697-8709	triangularis	_	
46-20	8710-8711	[	_	
46-21	8711-8712	Z	_	
46-22	8712-8713	 	_	
46-23	8713-8714	=	_	
46-24	8714-8715	 	_	
46-25	8715-8719	4.39	_	
46-26	8719-8720	;	_	
46-27	8721-8732	whole-brain	_	
46-28	8732-8733	,	_	
46-29	8734-8744	voxel-wise	_	
46-30	8745-8758	FWE-corrected	_	
46-31	8759-8760	p	_	
46-32	8760-8761	 	_	
46-33	8761-8762	=	_	
46-34	8762-8763	 	_	
46-35	8763-8767	0.03	_	
46-36	8767-8768	;	_	
46-37	8769-8772	ηp2	_	
46-38	8773-8774	(	_	
46-39	8774-8778	peak	_	
46-40	8778-8779	)	_	
46-41	8779-8780	 	_	
46-42	8780-8781	=	_	
46-43	8781-8782	 	_	
46-44	8782-8787	4.32%	_	
46-45	8787-8788	;	_	
46-46	8789-8792	Fig	_	
46-47	8792-8793	.	_	
46-48	8794-8795	1	_	
46-49	8796-8797	-	_	
46-50	8798-8802	Part	_	
46-51	8803-8804	A	_	
46-52	8804-8805	]	_	
46-53	8805-8806	,	_	
46-54	8807-8812	where	_	
46-55	8813-8817	risk	_	
46-56	8818-8824	allele	_	
46-57	8825-8826	A	_	
46-58	8827-8830	was	_	
46-59	8831-8841	associated	_	
46-60	8842-8846	with	_	
46-61	8847-8853	higher	_	
46-62	8854-8862	regional	_	
46-63	8863-8873	activation	_	
46-64	8874-8876	in	_	
46-65	8877-8879	BD	_	
46-66	8879-8880	,	_	
46-67	8881-8884	but	_	
46-68	8885-8888	the	_	
46-69	8889-8896	reverse	_	
46-70	8897-8900	was	_	
46-71	8901-8905	seen	_	
46-72	8906-8908	in	_	
46-73	8909-8916	healthy	_	
46-74	8917-8927	volunteers	_	
46-75	8927-8928	.	_	

#Text=This is indeed the area showing the highest activation in verbal fluency (vs. word repetition), and has been frequently attributed to phonological processing.
47-1	8929-8933	This	_	
47-2	8934-8936	is	_	
47-3	8937-8943	indeed	_	
47-4	8944-8947	the	_	
47-5	8948-8952	area	_	
47-6	8953-8960	showing	_	
47-7	8961-8964	the	_	
47-8	8965-8972	highest	_	
47-9	8973-8983	activation	_	
47-10	8984-8986	in	_	
47-11	8987-8993	verbal	_	
47-12	8994-9001	fluency	_	
47-13	9002-9003	(	_	
47-14	9003-9005	vs	_	
47-15	9005-9006	.	_	
47-16	9007-9011	word	_	
47-17	9012-9022	repetition	_	
47-18	9022-9023	)	_	
47-19	9023-9024	,	_	
47-20	9025-9028	and	_	
47-21	9029-9032	has	_	
47-22	9033-9037	been	_	
47-23	9038-9048	frequently	_	
47-24	9049-9059	attributed	_	
47-25	9060-9062	to	_	
47-26	9063-9075	phonological	_	
47-27	9076-9086	processing	_	
47-28	9086-9087	.	_	

#Text=The latter genotype effect in healthy volunteers has been independently found in the same area during theory-of-mind.
48-1	9088-9091	The	_	
48-2	9092-9098	latter	_	
48-3	9099-9107	genotype	_	
48-4	9108-9114	effect	_	
48-5	9115-9117	in	_	
48-6	9118-9125	healthy	_	
48-7	9126-9136	volunteers	_	
48-8	9137-9140	has	_	
48-9	9141-9145	been	_	
48-10	9146-9159	independently	_	
48-11	9160-9165	found	_	
48-12	9166-9168	in	_	
48-13	9169-9172	the	_	
48-14	9173-9177	same	_	
48-15	9178-9182	area	_	
48-16	9183-9189	during	_	
48-17	9190-9204	theory-of-mind	_	
48-18	9204-9205	.	_	

#Text=A report in BD, or verbal fluency for that matter, is unprecedented.
49-1	9206-9207	A	_	
49-2	9208-9214	report	_	
49-3	9215-9217	in	_	
49-4	9218-9220	BD	_	
49-5	9220-9221	,	_	
49-6	9222-9224	or	_	
49-7	9225-9231	verbal	_	
49-8	9232-9239	fluency	_	
49-9	9240-9243	for	_	
49-10	9244-9248	that	_	
49-11	9249-9255	matter	_	
49-12	9255-9256	,	_	
49-13	9257-9259	is	_	
49-14	9260-9273	unprecedented	_	
49-15	9273-9274	.	_	

#Text=Effects of ZNF804A rs1344706 on functional connectivity
#Text=– Regions showing an effect of ZNF804A rs1344706 genotype.
50-1	9275-9282	Effects	_	
50-2	9283-9285	of	_	
50-3	9286-9293	ZNF804A	_	
50-4	9294-9303	rs1344706	_	
50-5	9304-9306	on	_	
50-6	9307-9317	functional	_	
50-7	9318-9330	connectivity	_	
50-8	9331-9332	–	_	
50-9	9333-9340	Regions	_	
50-10	9341-9348	showing	_	
50-11	9349-9351	an	_	
50-12	9352-9358	effect	_	
50-13	9359-9361	of	_	
50-14	9362-9369	ZNF804A	_	
50-15	9370-9379	rs1344706	_	
50-16	9380-9388	genotype	_	
50-17	9388-9389	.	_	

#Text=All inferences presented in this table correspond to statistically significant results (corrected for whole-brain multiple comparisons, voxel-level FWE, p < 0.05) and trends (with an uncorrected p < 0.001) for the same effect.
51-1	9390-9393	All	_	
51-2	9394-9404	inferences	_	
51-3	9405-9414	presented	_	
51-4	9415-9417	in	_	
51-5	9418-9422	this	_	
51-6	9423-9428	table	_	
51-7	9429-9439	correspond	_	
51-8	9440-9442	to	_	
51-9	9443-9456	statistically	_	
51-10	9457-9468	significant	_	
51-11	9469-9476	results	_	
51-12	9477-9478	(	_	
51-13	9478-9487	corrected	_	
51-14	9488-9491	for	_	
51-15	9492-9503	whole-brain	_	
51-16	9504-9512	multiple	_	
51-17	9513-9524	comparisons	_	
51-18	9524-9525	,	_	
51-19	9526-9537	voxel-level	_	
51-20	9538-9541	FWE	_	
51-21	9541-9542	,	_	
51-22	9543-9544	p	_	
51-23	9544-9545	 	_	
51-24	9545-9546	<	_	
51-25	9546-9547	 	_	
51-26	9547-9551	0.05	_	
51-27	9551-9552	)	_	
51-28	9553-9556	and	_	
51-29	9557-9563	trends	_	
51-30	9564-9565	(	_	
51-31	9565-9569	with	_	
51-32	9570-9572	an	_	
51-33	9573-9584	uncorrected	_	
51-34	9585-9586	p	_	
51-35	9586-9587	 	_	
51-36	9587-9588	<	_	
51-37	9588-9589	 	_	
51-38	9589-9594	0.001	_	
51-39	9594-9595	)	_	
51-40	9596-9599	for	_	
51-41	9600-9603	the	_	
51-42	9604-9608	same	_	
51-43	9609-9615	effect	_	
51-44	9615-9616	.	_	

#Text=P-values (FWE corrected) and cluster size (k) are given only for the areas showing statistically significant effects.
52-1	9617-9625	P-values	_	
52-2	9626-9627	(	_	
52-3	9627-9630	FWE	_	
52-4	9631-9640	corrected	_	
52-5	9640-9641	)	_	
52-6	9642-9645	and	_	
52-7	9646-9653	cluster	_	
52-8	9654-9658	size	_	
52-9	9659-9660	(	_	
52-10	9660-9661	k	_	
52-11	9661-9662	)	_	
52-12	9663-9666	are	_	
52-13	9667-9672	given	_	
52-14	9673-9677	only	_	
52-15	9678-9681	for	_	
52-16	9682-9685	the	_	
52-17	9686-9691	areas	_	
52-18	9692-9699	showing	_	
52-19	9700-9713	statistically	_	
52-20	9714-9725	significant	_	
52-21	9726-9733	effects	_	
52-22	9733-9734	.	_	

#Text=Table 1\t \t
#Text=Contrasts\tRegions\tCoordinates (x y z)\tZ-score (Z), voxel-wise FWE corrected p-value (p), cluster size (k)\t \t1.
53-1	9735-9740	Table	_	
53-2	9741-9742	1	_	
53-3	9746-9755	Contrasts	_	
53-4	9756-9763	Regions	_	
53-5	9764-9775	Coordinates	_	
53-6	9776-9777	(	_	
53-7	9777-9778	x	_	
53-8	9779-9780	y	_	
53-9	9781-9782	z	_	
53-10	9782-9783	)	_	
53-11	9784-9791	Z-score	_	
53-12	9792-9793	(	_	
53-13	9793-9794	Z	_	
53-14	9794-9795	)	_	
53-15	9795-9796	,	_	
53-16	9797-9807	voxel-wise	_	
53-17	9808-9811	FWE	_	
53-18	9812-9821	corrected	_	
53-19	9822-9829	p-value	_	
53-20	9830-9831	(	_	
53-21	9831-9832	p	_	
53-22	9832-9833	)	_	
53-23	9833-9834	,	_	
53-24	9835-9842	cluster	_	
53-25	9843-9847	size	_	
53-26	9848-9849	(	_	
53-27	9849-9850	k	_	
53-28	9850-9851	)	_	
53-29	9854-9855	1	_	
53-30	9855-9856	.	_	

#Text=Regional activations\t \t\t \tZNF804Agenotype-by-diagnosis interaction\t \t\t \t(AA > AC + CC) & (BD > CON)\tL Inferior frontal gyrus, pars triangularis/opercularis\t−48 14 10\tZ = 4.39, p = 0.026, k = 4\t \tL Insula\t−42 14 8\tZ = 3.13\t \t2.
54-1	9857-9865	Regional	_	
54-2	9866-9877	activations	_	
54-3	9883-9911	ZNF804Agenotype-by-diagnosis	_	
54-4	9912-9923	interaction	_	
54-5	9929-9930	(	_	
54-6	9930-9932	AA	_	
54-7	9932-9933	 	_	
54-8	9933-9934	>	_	
54-9	9934-9935	 	_	
54-10	9935-9937	AC	_	
54-11	9937-9938	 	_	
54-12	9938-9939	+	_	
54-13	9939-9940	 	_	
54-14	9940-9942	CC	_	
54-15	9942-9943	)	_	
54-16	9944-9945	&	_	
54-17	9946-9947	(	_	
54-18	9947-9949	BD	_	
54-19	9949-9950	 	_	
54-20	9950-9951	>	_	
54-21	9951-9952	 	_	
54-22	9952-9955	CON	_	
54-23	9955-9956	)	_	
54-24	9957-9958	L	_	
54-25	9959-9967	Inferior	_	
54-26	9968-9975	frontal	_	
54-27	9976-9981	gyrus	_	
54-28	9981-9982	,	_	
54-29	9983-9987	pars	_	
54-30	9988-10000	triangularis	_	
54-31	10000-10001	/	_	
54-32	10001-10012	opercularis	_	
54-33	10013-10014	−	_	
54-34	10014-10016	48	_	
54-35	10017-10019	14	_	
54-36	10020-10022	10	_	
54-37	10023-10024	Z	_	
54-38	10024-10025	 	_	
54-39	10025-10026	=	_	
54-40	10026-10027	 	_	
54-41	10027-10031	4.39	_	
54-42	10031-10032	,	_	
54-43	10033-10034	p	_	
54-44	10034-10035	 	_	
54-45	10035-10036	=	_	
54-46	10036-10037	 	_	
54-47	10037-10042	0.026	_	
54-48	10042-10043	,	_	
54-49	10044-10045	k	_	
54-50	10045-10046	 	_	
54-51	10046-10047	=	_	
54-52	10047-10048	 	_	
54-53	10048-10049	4	_	
54-54	10052-10053	L	_	
54-55	10054-10060	Insula	_	
54-56	10061-10062	−	_	
54-57	10062-10064	42	_	
54-58	10065-10067	14	_	
54-59	10068-10069	8	_	
54-60	10070-10071	Z	_	
54-61	10071-10072	 	_	
54-62	10072-10073	=	_	
54-63	10073-10074	 	_	
54-64	10074-10078	3.13	_	
54-65	10081-10082	2	_	
54-66	10082-10083	.	_	

#Text=Functional Connectivity with Left Precentral gyrus/inferior frontal gyrus (peak of the main effect of task)\t \tMain effect of ZNF804A genotype\t \tAA < AC + CC a\tWhite matter near L Inferior frontal gyrus, pars triangularis/opercularis\t−28 26 22\tZ = 4.42, p = 0.021, k = 9\t \tL Posterior cingulate gyrus\t−8 −52 32\tZ = 4.34, p = 0.029, k = 11\t \tLeft Precuneus\t−6 −54 30\tZ = 4.27, p = 0.04 (same cluster as above)\t \t−8 −50 34\tZ = 4.25, p = 0.04 (same cluster as above)\t \tR Lingual gyrus\t14 −84 −4\tZ = 3.25\t \tL Middle occipital gyrus\t−36 −82 30\tZ = 3.46\t \t−42 −76 26\tZ = 3.48\t \tL Angular gyrus\t−44 −76 30\tZ = 3.34\t \tR Cuneus\t20 −68 22\tZ = 3.89\t \tR Superior Occipital gyrus\t22 −68 28\tZ = 3.18\t \tR Precuneus\t20 −66 22\tZ = 3.78\t \t4 −58 32\tZ = 3.88\t \tL Cuneus\t−6 −66 28\tZ = 3.37\t \tL Lingual gyrus\t−8 −64 6\tZ = 3.2\t \tR Calcarine sulcus (occipital gyrus)\t20 −62 12\tZ = 3.44\t \tL Calcarine sulcus (occipital gyrus)\t−12 −62 12\tZ = 3.84\t \tR Posterior Cingulate gyrus\t4 −58 30\tZ = 3.86\t \tR Middle Cingulate gyrus\t2 −54 32\tZ = 3.59\t \tR Angular gyrus\t52 −52 34\tZ = 3.25\t \tAnterior Cerebellum (Vermis IV/V)\t2 −46 −12\tZ = 3.16\t \tAnterior Cerebellum (Vermis III)\t0 −40 −14\tZ = 3.77\t \tL Middle cingulate gyrus\t0 −36 34\tZ = 4.14\t \tR Hippocampus\t18 −34 8\tZ = 3.85\t \t42 −18 −18\tZ = 3.55\t \tR Superior temporal gyrus\t44 −32 8\tZ = 3.80\t \t54 −30 8\tZ = 4.04\t \tR Thalamus\t18 −32 8\tZ = 3.71\t \tR Insula\t36 −18 8\tZ = 3.32\t \t38 3 16\tZ = 3.14\t \tR Fusiform gyrus\t42 −18 −20\tZ = 3.54\t \tR Rolandic operculum\t54 −16 10\tZ = 3.43\t \t58 4 10\tZ = 3.68\t \tR Transverse temporal gyrus\t52 −16 8\tZ = 3.52\t \t60 −2 6\tZ = 3.2\t \tR Postcentral gyrus\t50 −16 26\tZ = 3.74\t \t52 −14 26\tZ = 3.80\t \tR Putamen\t34 −10 4\tZ = 3.23\t \tR Precentral gyrus\t44 2 24\tZ = 3.29\t \tR Inferior frontal gyrus, pars opercularis\t38 4 22\tZ = 3.97\t \tL Caudate nucleus/Septal nuclei\t0 6 4\tZ = 3.38\t \tWhite matter near L Inferior frontal gyrus, pars opercularis\t−34 8 24\tZ = 3.2\t \tR Inferior frontal gyrus, pars triangularis\t46 18 20\tZ = 3.76\t \t48 32 20\tZ = 3.46\t \tR Middle frontal gyrus\t30 26 22\tZ = 3.94\t \t46 34 20\tZ = 3.42\t \tL Superior frontal gyrus, medial\t−28 26 22\tZ = 3.41\t \tWhite matter near L Anterior cingulate gyrus\t−6 28 20\tZ = 4.01\t \t−16 28 22\tZ = 3.90\t \tL Middle frontal gyrus\t−26 32 24\tZ = 3.58\t \tR Anterior cingulate gyrus\t2 32 18\tZ = 3.53\t \t
#Text=AA, adenine-adenine; AC, adenine-cytosine; CC – cytosine-cytosine; CON, controls, BD, bipolar disorder; SCZ, schizophrenia; PSYCH, psychosis patients; R, right; L, left.
55-1	10084-10094	Functional	_	
55-2	10095-10107	Connectivity	_	
55-3	10108-10112	with	_	
55-4	10113-10117	Left	_	
55-5	10118-10128	Precentral	_	
55-6	10129-10134	gyrus	_	
55-7	10134-10135	/	_	
55-8	10135-10143	inferior	_	
55-9	10144-10151	frontal	_	
55-10	10152-10157	gyrus	_	
55-11	10158-10159	(	_	
55-12	10159-10163	peak	_	
55-13	10164-10166	of	_	
55-14	10167-10170	the	_	
55-15	10171-10175	main	_	
55-16	10176-10182	effect	_	
55-17	10183-10185	of	_	
55-18	10186-10190	task	_	
55-19	10190-10191	)	_	
55-20	10194-10198	Main	_	
55-21	10199-10205	effect	_	
55-22	10206-10208	of	_	
55-23	10209-10216	ZNF804A	_	
55-24	10217-10225	genotype	_	
55-25	10228-10230	AA	_	
55-26	10230-10231	 	_	
55-27	10231-10232	<	_	
55-28	10232-10233	 	_	
55-29	10233-10235	AC	_	
55-30	10235-10236	 	_	
55-31	10236-10237	+	_	
55-32	10237-10238	 	_	
55-33	10238-10240	CC	_	
55-34	10241-10242	a	_	
55-35	10243-10248	White	_	
55-36	10249-10255	matter	_	
55-37	10256-10260	near	_	
55-38	10261-10262	L	_	
55-39	10263-10271	Inferior	_	
55-40	10272-10279	frontal	_	
55-41	10280-10285	gyrus	_	
55-42	10285-10286	,	_	
55-43	10287-10291	pars	_	
55-44	10292-10304	triangularis	_	
55-45	10304-10305	/	_	
55-46	10305-10316	opercularis	_	
55-47	10317-10318	−	_	
55-48	10318-10320	28	_	
55-49	10321-10323	26	_	
55-50	10324-10326	22	_	
55-51	10327-10328	Z	_	
55-52	10328-10329	 	_	
55-53	10329-10330	=	_	
55-54	10330-10331	 	_	
55-55	10331-10335	4.42	_	
55-56	10335-10336	,	_	
55-57	10337-10338	p	_	
55-58	10338-10339	 	_	
55-59	10339-10340	=	_	
55-60	10340-10341	 	_	
55-61	10341-10346	0.021	_	
55-62	10346-10347	,	_	
55-63	10348-10349	k	_	
55-64	10349-10350	 	_	
55-65	10350-10351	=	_	
55-66	10351-10352	 	_	
55-67	10352-10353	9	_	
55-68	10356-10357	L	_	
55-69	10358-10367	Posterior	_	
55-70	10368-10377	cingulate	_	
55-71	10378-10383	gyrus	_	
55-72	10384-10385	−	_	
55-73	10385-10386	8	_	
55-74	10387-10388	−	_	
55-75	10388-10390	52	_	
55-76	10391-10393	32	_	
55-77	10394-10395	Z	_	
55-78	10395-10396	 	_	
55-79	10396-10397	=	_	
55-80	10397-10398	 	_	
55-81	10398-10402	4.34	_	
55-82	10402-10403	,	_	
55-83	10404-10405	p	_	
55-84	10405-10406	 	_	
55-85	10406-10407	=	_	
55-86	10407-10408	 	_	
55-87	10408-10413	0.029	_	
55-88	10413-10414	,	_	
55-89	10415-10416	k	_	
55-90	10416-10417	 	_	
55-91	10417-10418	=	_	
55-92	10418-10419	 	_	
55-93	10419-10421	11	_	
55-94	10424-10428	Left	_	
55-95	10429-10438	Precuneus	_	
55-96	10439-10440	−	_	
55-97	10440-10441	6	_	
55-98	10442-10443	−	_	
55-99	10443-10445	54	_	
55-100	10446-10448	30	_	
55-101	10449-10450	Z	_	
55-102	10450-10451	 	_	
55-103	10451-10452	=	_	
55-104	10452-10453	 	_	
55-105	10453-10457	4.27	_	
55-106	10457-10458	,	_	
55-107	10459-10460	p	_	
55-108	10460-10461	 	_	
55-109	10461-10462	=	_	
55-110	10462-10463	 	_	
55-111	10463-10467	0.04	_	
55-112	10468-10469	(	_	
55-113	10469-10473	same	_	
55-114	10474-10481	cluster	_	
55-115	10482-10484	as	_	
55-116	10485-10490	above	_	
55-117	10490-10491	)	_	
55-118	10494-10495	−	_	
55-119	10495-10496	8	_	
55-120	10497-10498	−	_	
55-121	10498-10500	50	_	
55-122	10501-10503	34	_	
55-123	10504-10505	Z	_	
55-124	10505-10506	 	_	
55-125	10506-10507	=	_	
55-126	10507-10508	 	_	
55-127	10508-10512	4.25	_	
55-128	10512-10513	,	_	
55-129	10514-10515	p	_	
55-130	10515-10516	 	_	
55-131	10516-10517	=	_	
55-132	10517-10518	 	_	
55-133	10518-10522	0.04	_	
55-134	10523-10524	(	_	
55-135	10524-10528	same	_	
55-136	10529-10536	cluster	_	
55-137	10537-10539	as	_	
55-138	10540-10545	above	_	
55-139	10545-10546	)	_	
55-140	10549-10550	R	_	
55-141	10551-10558	Lingual	_	
55-142	10559-10564	gyrus	_	
55-143	10565-10567	14	_	
55-144	10568-10569	−	_	
55-145	10569-10571	84	_	
55-146	10572-10573	−	_	
55-147	10573-10574	4	_	
55-148	10575-10576	Z	_	
55-149	10576-10577	 	_	
55-150	10577-10578	=	_	
55-151	10578-10579	 	_	
55-152	10579-10583	3.25	_	
55-153	10586-10587	L	_	
55-154	10588-10594	Middle	_	
55-155	10595-10604	occipital	_	
55-156	10605-10610	gyrus	_	
55-157	10611-10612	−	_	
55-158	10612-10614	36	_	
55-159	10615-10616	−	_	
55-160	10616-10618	82	_	
55-161	10619-10621	30	_	
55-162	10622-10623	Z	_	
55-163	10623-10624	 	_	
55-164	10624-10625	=	_	
55-165	10625-10626	 	_	
55-166	10626-10630	3.46	_	
55-167	10633-10634	−	_	
55-168	10634-10636	42	_	
55-169	10637-10638	−	_	
55-170	10638-10640	76	_	
55-171	10641-10643	26	_	
55-172	10644-10645	Z	_	
55-173	10645-10646	 	_	
55-174	10646-10647	=	_	
55-175	10647-10648	 	_	
55-176	10648-10652	3.48	_	
55-177	10655-10656	L	_	
55-178	10657-10664	Angular	_	
55-179	10665-10670	gyrus	_	
55-180	10671-10672	−	_	
55-181	10672-10674	44	_	
55-182	10675-10676	−	_	
55-183	10676-10678	76	_	
55-184	10679-10681	30	_	
55-185	10682-10683	Z	_	
55-186	10683-10684	 	_	
55-187	10684-10685	=	_	
55-188	10685-10686	 	_	
55-189	10686-10690	3.34	_	
55-190	10693-10694	R	_	
55-191	10695-10701	Cuneus	_	
55-192	10702-10704	20	_	
55-193	10705-10706	−	_	
55-194	10706-10708	68	_	
55-195	10709-10711	22	_	
55-196	10712-10713	Z	_	
55-197	10713-10714	 	_	
55-198	10714-10715	=	_	
55-199	10715-10716	 	_	
55-200	10716-10720	3.89	_	
55-201	10723-10724	R	_	
55-202	10725-10733	Superior	_	
55-203	10734-10743	Occipital	_	
55-204	10744-10749	gyrus	_	
55-205	10750-10752	22	_	
55-206	10753-10754	−	_	
55-207	10754-10756	68	_	
55-208	10757-10759	28	_	
55-209	10760-10761	Z	_	
55-210	10761-10762	 	_	
55-211	10762-10763	=	_	
55-212	10763-10764	 	_	
55-213	10764-10768	3.18	_	
55-214	10771-10772	R	_	
55-215	10773-10782	Precuneus	_	
55-216	10783-10785	20	_	
55-217	10786-10787	−	_	
55-218	10787-10789	66	_	
55-219	10790-10792	22	_	
55-220	10793-10794	Z	_	
55-221	10794-10795	 	_	
55-222	10795-10796	=	_	
55-223	10796-10797	 	_	
55-224	10797-10801	3.78	_	
55-225	10804-10805	4	_	
55-226	10806-10807	−	_	
55-227	10807-10809	58	_	
55-228	10810-10812	32	_	
55-229	10813-10814	Z	_	
55-230	10814-10815	 	_	
55-231	10815-10816	=	_	
55-232	10816-10817	 	_	
55-233	10817-10821	3.88	_	
55-234	10824-10825	L	_	
55-235	10826-10832	Cuneus	_	
55-236	10833-10834	−	_	
55-237	10834-10835	6	_	
55-238	10836-10837	−	_	
55-239	10837-10839	66	_	
55-240	10840-10842	28	_	
55-241	10843-10844	Z	_	
55-242	10844-10845	 	_	
55-243	10845-10846	=	_	
55-244	10846-10847	 	_	
55-245	10847-10851	3.37	_	
55-246	10854-10855	L	_	
55-247	10856-10863	Lingual	_	
55-248	10864-10869	gyrus	_	
55-249	10870-10871	−	_	
55-250	10871-10872	8	_	
55-251	10873-10874	−	_	
55-252	10874-10876	64	_	
55-253	10877-10878	6	_	
55-254	10879-10880	Z	_	
55-255	10880-10881	 	_	
55-256	10881-10882	=	_	
55-257	10882-10883	 	_	
55-258	10883-10886	3.2	_	
55-259	10889-10890	R	_	
55-260	10891-10900	Calcarine	_	
55-261	10901-10907	sulcus	_	
55-262	10908-10909	(	_	
55-263	10909-10918	occipital	_	
55-264	10919-10924	gyrus	_	
55-265	10924-10925	)	_	
55-266	10926-10928	20	_	
55-267	10929-10930	−	_	
55-268	10930-10932	62	_	
55-269	10933-10935	12	_	
55-270	10936-10937	Z	_	
55-271	10937-10938	 	_	
55-272	10938-10939	=	_	
55-273	10939-10940	 	_	
55-274	10940-10944	3.44	_	
55-275	10947-10948	L	_	
55-276	10949-10958	Calcarine	_	
55-277	10959-10965	sulcus	_	
55-278	10966-10967	(	_	
55-279	10967-10976	occipital	_	
55-280	10977-10982	gyrus	_	
55-281	10982-10983	)	_	
55-282	10984-10985	−	_	
55-283	10985-10987	12	_	
55-284	10988-10989	−	_	
55-285	10989-10991	62	_	
55-286	10992-10994	12	_	
55-287	10995-10996	Z	_	
55-288	10996-10997	 	_	
55-289	10997-10998	=	_	
55-290	10998-10999	 	_	
55-291	10999-11003	3.84	_	
55-292	11006-11007	R	_	
55-293	11008-11017	Posterior	_	
55-294	11018-11027	Cingulate	_	
55-295	11028-11033	gyrus	_	
55-296	11034-11035	4	_	
55-297	11036-11037	−	_	
55-298	11037-11039	58	_	
55-299	11040-11042	30	_	
55-300	11043-11044	Z	_	
55-301	11044-11045	 	_	
55-302	11045-11046	=	_	
55-303	11046-11047	 	_	
55-304	11047-11051	3.86	_	
55-305	11054-11055	R	_	
55-306	11056-11062	Middle	_	
55-307	11063-11072	Cingulate	_	
55-308	11073-11078	gyrus	_	
55-309	11079-11080	2	_	
55-310	11081-11082	−	_	
55-311	11082-11084	54	_	
55-312	11085-11087	32	_	
55-313	11088-11089	Z	_	
55-314	11089-11090	 	_	
55-315	11090-11091	=	_	
55-316	11091-11092	 	_	
55-317	11092-11096	3.59	_	
55-318	11099-11100	R	_	
55-319	11101-11108	Angular	_	
55-320	11109-11114	gyrus	_	
55-321	11115-11117	52	_	
55-322	11118-11119	−	_	
55-323	11119-11121	52	_	
55-324	11122-11124	34	_	
55-325	11125-11126	Z	_	
55-326	11126-11127	 	_	
55-327	11127-11128	=	_	
55-328	11128-11129	 	_	
55-329	11129-11133	3.25	_	
55-330	11136-11144	Anterior	_	
55-331	11145-11155	Cerebellum	_	
55-332	11156-11157	(	_	
55-333	11157-11163	Vermis	_	
55-334	11164-11166	IV	_	
55-335	11166-11167	/	_	
55-336	11167-11168	V	_	
55-337	11168-11169	)	_	
55-338	11170-11171	2	_	
55-339	11172-11173	−	_	
55-340	11173-11175	46	_	
55-341	11176-11177	−	_	
55-342	11177-11179	12	_	
55-343	11180-11181	Z	_	
55-344	11181-11182	 	_	
55-345	11182-11183	=	_	
55-346	11183-11184	 	_	
55-347	11184-11188	3.16	_	
55-348	11191-11199	Anterior	_	
55-349	11200-11210	Cerebellum	_	
55-350	11211-11212	(	_	
55-351	11212-11218	Vermis	_	
55-352	11219-11222	III	_	
55-353	11222-11223	)	_	
55-354	11224-11225	0	_	
55-355	11226-11227	−	_	
55-356	11227-11229	40	_	
55-357	11230-11231	−	_	
55-358	11231-11233	14	_	
55-359	11234-11235	Z	_	
55-360	11235-11236	 	_	
55-361	11236-11237	=	_	
55-362	11237-11238	 	_	
55-363	11238-11242	3.77	_	
55-364	11245-11246	L	_	
55-365	11247-11253	Middle	_	
55-366	11254-11263	cingulate	_	
55-367	11264-11269	gyrus	_	
55-368	11270-11271	0	_	
55-369	11272-11273	−	_	
55-370	11273-11275	36	_	
55-371	11276-11278	34	_	
55-372	11279-11280	Z	_	
55-373	11280-11281	 	_	
55-374	11281-11282	=	_	
55-375	11282-11283	 	_	
55-376	11283-11287	4.14	_	
55-377	11290-11291	R	_	
55-378	11292-11303	Hippocampus	_	
55-379	11304-11306	18	_	
55-380	11307-11308	−	_	
55-381	11308-11310	34	_	
55-382	11311-11312	8	_	
55-383	11313-11314	Z	_	
55-384	11314-11315	 	_	
55-385	11315-11316	=	_	
55-386	11316-11317	 	_	
55-387	11317-11321	3.85	_	
55-388	11324-11326	42	_	
55-389	11327-11328	−	_	
55-390	11328-11330	18	_	
55-391	11331-11332	−	_	
55-392	11332-11334	18	_	
55-393	11335-11336	Z	_	
55-394	11336-11337	 	_	
55-395	11337-11338	=	_	
55-396	11338-11339	 	_	
55-397	11339-11343	3.55	_	
55-398	11346-11347	R	_	
55-399	11348-11356	Superior	_	
55-400	11357-11365	temporal	_	
55-401	11366-11371	gyrus	_	
55-402	11372-11374	44	_	
55-403	11375-11376	−	_	
55-404	11376-11378	32	_	
55-405	11379-11380	8	_	
55-406	11381-11382	Z	_	
55-407	11382-11383	 	_	
55-408	11383-11384	=	_	
55-409	11384-11385	 	_	
55-410	11385-11389	3.80	_	
55-411	11392-11394	54	_	
55-412	11395-11396	−	_	
55-413	11396-11398	30	_	
55-414	11399-11400	8	_	
55-415	11401-11402	Z	_	
55-416	11402-11403	 	_	
55-417	11403-11404	=	_	
55-418	11404-11405	 	_	
55-419	11405-11409	4.04	_	
55-420	11412-11413	R	_	
55-421	11414-11422	Thalamus	_	
55-422	11423-11425	18	_	
55-423	11426-11427	−	_	
55-424	11427-11429	32	_	
55-425	11430-11431	8	_	
55-426	11432-11433	Z	_	
55-427	11433-11434	 	_	
55-428	11434-11435	=	_	
55-429	11435-11436	 	_	
55-430	11436-11440	3.71	_	
55-431	11443-11444	R	_	
55-432	11445-11451	Insula	_	
55-433	11452-11454	36	_	
55-434	11455-11456	−	_	
55-435	11456-11458	18	_	
55-436	11459-11460	8	_	
55-437	11461-11462	Z	_	
55-438	11462-11463	 	_	
55-439	11463-11464	=	_	
55-440	11464-11465	 	_	
55-441	11465-11469	3.32	_	
55-442	11472-11474	38	_	
55-443	11475-11476	3	_	
55-444	11477-11479	16	_	
55-445	11480-11481	Z	_	
55-446	11481-11482	 	_	
55-447	11482-11483	=	_	
55-448	11483-11484	 	_	
55-449	11484-11488	3.14	_	
55-450	11491-11492	R	_	
55-451	11493-11501	Fusiform	_	
55-452	11502-11507	gyrus	_	
55-453	11508-11510	42	_	
55-454	11511-11512	−	_	
55-455	11512-11514	18	_	
55-456	11515-11516	−	_	
55-457	11516-11518	20	_	
55-458	11519-11520	Z	_	
55-459	11520-11521	 	_	
55-460	11521-11522	=	_	
55-461	11522-11523	 	_	
55-462	11523-11527	3.54	_	
55-463	11530-11531	R	_	
55-464	11532-11540	Rolandic	_	
55-465	11541-11550	operculum	_	
55-466	11551-11553	54	_	
55-467	11554-11555	−	_	
55-468	11555-11557	16	_	
55-469	11558-11560	10	_	
55-470	11561-11562	Z	_	
55-471	11562-11563	 	_	
55-472	11563-11564	=	_	
55-473	11564-11565	 	_	
55-474	11565-11569	3.43	_	
55-475	11572-11574	58	_	
55-476	11575-11576	4	_	
55-477	11577-11579	10	_	
55-478	11580-11581	Z	_	
55-479	11581-11582	 	_	
55-480	11582-11583	=	_	
55-481	11583-11584	 	_	
55-482	11584-11588	3.68	_	
55-483	11591-11592	R	_	
55-484	11593-11603	Transverse	_	
55-485	11604-11612	temporal	_	
55-486	11613-11618	gyrus	_	
55-487	11619-11621	52	_	
55-488	11622-11623	−	_	
55-489	11623-11625	16	_	
55-490	11626-11627	8	_	
55-491	11628-11629	Z	_	
55-492	11629-11630	 	_	
55-493	11630-11631	=	_	
55-494	11631-11632	 	_	
55-495	11632-11636	3.52	_	
55-496	11639-11641	60	_	
55-497	11642-11643	−	_	
55-498	11643-11644	2	_	
55-499	11645-11646	6	_	
55-500	11647-11648	Z	_	
55-501	11648-11649	 	_	
55-502	11649-11650	=	_	
55-503	11650-11651	 	_	
55-504	11651-11654	3.2	_	
55-505	11657-11658	R	_	
55-506	11659-11670	Postcentral	_	
55-507	11671-11676	gyrus	_	
55-508	11677-11679	50	_	
55-509	11680-11681	−	_	
55-510	11681-11683	16	_	
55-511	11684-11686	26	_	
55-512	11687-11688	Z	_	
55-513	11688-11689	 	_	
55-514	11689-11690	=	_	
55-515	11690-11691	 	_	
55-516	11691-11695	3.74	_	
55-517	11698-11700	52	_	
55-518	11701-11702	−	_	
55-519	11702-11704	14	_	
55-520	11705-11707	26	_	
55-521	11708-11709	Z	_	
55-522	11709-11710	 	_	
55-523	11710-11711	=	_	
55-524	11711-11712	 	_	
55-525	11712-11716	3.80	_	
55-526	11719-11720	R	_	
55-527	11721-11728	Putamen	_	
55-528	11729-11731	34	_	
55-529	11732-11733	−	_	
55-530	11733-11735	10	_	
55-531	11736-11737	4	_	
55-532	11738-11739	Z	_	
55-533	11739-11740	 	_	
55-534	11740-11741	=	_	
55-535	11741-11742	 	_	
55-536	11742-11746	3.23	_	
55-537	11749-11750	R	_	
55-538	11751-11761	Precentral	_	
55-539	11762-11767	gyrus	_	
55-540	11768-11770	44	_	
55-541	11771-11772	2	_	
55-542	11773-11775	24	_	
55-543	11776-11777	Z	_	
55-544	11777-11778	 	_	
55-545	11778-11779	=	_	
55-546	11779-11780	 	_	
55-547	11780-11784	3.29	_	
55-548	11787-11788	R	_	
55-549	11789-11797	Inferior	_	
55-550	11798-11805	frontal	_	
55-551	11806-11811	gyrus	_	
55-552	11811-11812	,	_	
55-553	11813-11817	pars	_	
55-554	11818-11829	opercularis	_	
55-555	11830-11832	38	_	
55-556	11833-11834	4	_	
55-557	11835-11837	22	_	
55-558	11838-11839	Z	_	
55-559	11839-11840	 	_	
55-560	11840-11841	=	_	
55-561	11841-11842	 	_	
55-562	11842-11846	3.97	_	
55-563	11849-11850	L	_	
55-564	11851-11858	Caudate	_	
55-565	11859-11866	nucleus	_	
55-566	11866-11867	/	_	
55-567	11867-11873	Septal	_	
55-568	11874-11880	nuclei	_	
55-569	11881-11882	0	_	
55-570	11883-11884	6	_	
55-571	11885-11886	4	_	
55-572	11887-11888	Z	_	
55-573	11888-11889	 	_	
55-574	11889-11890	=	_	
55-575	11890-11891	 	_	
55-576	11891-11895	3.38	_	
55-577	11898-11903	White	_	
55-578	11904-11910	matter	_	
55-579	11911-11915	near	_	
55-580	11916-11917	L	_	
55-581	11918-11926	Inferior	_	
55-582	11927-11934	frontal	_	
55-583	11935-11940	gyrus	_	
55-584	11940-11941	,	_	
55-585	11942-11946	pars	_	
55-586	11947-11958	opercularis	_	
55-587	11959-11960	−	_	
55-588	11960-11962	34	_	
55-589	11963-11964	8	_	
55-590	11965-11967	24	_	
55-591	11968-11969	Z	_	
55-592	11969-11970	 	_	
55-593	11970-11971	=	_	
55-594	11971-11972	 	_	
55-595	11972-11975	3.2	_	
55-596	11978-11979	R	_	
55-597	11980-11988	Inferior	_	
55-598	11989-11996	frontal	_	
55-599	11997-12002	gyrus	_	
55-600	12002-12003	,	_	
55-601	12004-12008	pars	_	
55-602	12009-12021	triangularis	_	
55-603	12022-12024	46	_	
55-604	12025-12027	18	_	
55-605	12028-12030	20	_	
55-606	12031-12032	Z	_	
55-607	12032-12033	 	_	
55-608	12033-12034	=	_	
55-609	12034-12035	 	_	
55-610	12035-12039	3.76	_	
55-611	12042-12044	48	_	
55-612	12045-12047	32	_	
55-613	12048-12050	20	_	
55-614	12051-12052	Z	_	
55-615	12052-12053	 	_	
55-616	12053-12054	=	_	
55-617	12054-12055	 	_	
55-618	12055-12059	3.46	_	
55-619	12062-12063	R	_	
55-620	12064-12070	Middle	_	
55-621	12071-12078	frontal	_	
55-622	12079-12084	gyrus	_	
55-623	12085-12087	30	_	
55-624	12088-12090	26	_	
55-625	12091-12093	22	_	
55-626	12094-12095	Z	_	
55-627	12095-12096	 	_	
55-628	12096-12097	=	_	
55-629	12097-12098	 	_	
55-630	12098-12102	3.94	_	
55-631	12105-12107	46	_	
55-632	12108-12110	34	_	
55-633	12111-12113	20	_	
55-634	12114-12115	Z	_	
55-635	12115-12116	 	_	
55-636	12116-12117	=	_	
55-637	12117-12118	 	_	
55-638	12118-12122	3.42	_	
55-639	12125-12126	L	_	
55-640	12127-12135	Superior	_	
55-641	12136-12143	frontal	_	
55-642	12144-12149	gyrus	_	
55-643	12149-12150	,	_	
55-644	12151-12157	medial	_	
55-645	12158-12159	−	_	
55-646	12159-12161	28	_	
55-647	12162-12164	26	_	
55-648	12165-12167	22	_	
55-649	12168-12169	Z	_	
55-650	12169-12170	 	_	
55-651	12170-12171	=	_	
55-652	12171-12172	 	_	
55-653	12172-12176	3.41	_	
55-654	12179-12184	White	_	
55-655	12185-12191	matter	_	
55-656	12192-12196	near	_	
55-657	12197-12198	L	_	
55-658	12199-12207	Anterior	_	
55-659	12208-12217	cingulate	_	
55-660	12218-12223	gyrus	_	
55-661	12224-12225	−	_	
55-662	12225-12226	6	_	
55-663	12227-12229	28	_	
55-664	12230-12232	20	_	
55-665	12233-12234	Z	_	
55-666	12234-12235	 	_	
55-667	12235-12236	=	_	
55-668	12236-12237	 	_	
55-669	12237-12241	4.01	_	
55-670	12244-12245	−	_	
55-671	12245-12247	16	_	
55-672	12248-12250	28	_	
55-673	12251-12253	22	_	
55-674	12254-12255	Z	_	
55-675	12255-12256	 	_	
55-676	12256-12257	=	_	
55-677	12257-12258	 	_	
55-678	12258-12262	3.90	_	
55-679	12265-12266	L	_	
55-680	12267-12273	Middle	_	
55-681	12274-12281	frontal	_	
55-682	12282-12287	gyrus	_	
55-683	12288-12289	−	_	
55-684	12289-12291	26	_	
55-685	12292-12294	32	_	
55-686	12295-12297	24	_	
55-687	12298-12299	Z	_	
55-688	12299-12300	 	_	
55-689	12300-12301	=	_	
55-690	12301-12302	 	_	
55-691	12302-12306	3.58	_	
55-692	12309-12310	R	_	
55-693	12311-12319	Anterior	_	
55-694	12320-12329	cingulate	_	
55-695	12330-12335	gyrus	_	
55-696	12336-12337	2	_	
55-697	12338-12340	32	_	
55-698	12341-12343	18	_	
55-699	12344-12345	Z	_	
55-700	12345-12346	 	_	
55-701	12346-12347	=	_	
55-702	12347-12348	 	_	
55-703	12348-12352	3.53	_	
55-704	12356-12358	AA	_	
55-705	12358-12359	,	_	
55-706	12360-12375	adenine-adenine	_	
55-707	12375-12376	;	_	
55-708	12377-12379	AC	_	
55-709	12379-12380	,	_	
55-710	12381-12397	adenine-cytosine	_	
55-711	12397-12398	;	_	
55-712	12399-12401	CC	_	
55-713	12402-12403	–	_	
55-714	12404-12421	cytosine-cytosine	_	
55-715	12421-12422	;	_	
55-716	12423-12426	CON	_	
55-717	12426-12427	,	_	
55-718	12428-12436	controls	_	
55-719	12436-12437	,	_	
55-720	12438-12440	BD	_	
55-721	12440-12441	,	_	
55-722	12442-12449	bipolar	_	
55-723	12450-12458	disorder	_	
55-724	12458-12459	;	_	
55-725	12460-12463	SCZ	_	
55-726	12463-12464	,	_	
55-727	12465-12478	schizophrenia	_	
55-728	12478-12479	;	_	
55-729	12480-12485	PSYCH	_	
55-730	12485-12486	,	_	
55-731	12487-12496	psychosis	_	
55-732	12497-12505	patients	_	
55-733	12505-12506	;	_	
55-734	12507-12508	R	_	
55-735	12508-12509	,	_	
55-736	12510-12515	right	_	
55-737	12515-12516	;	_	
55-738	12517-12518	L	_	
55-739	12518-12519	,	_	
55-740	12520-12524	left	_	
55-741	12524-12525	.	_	

#Text=Only present in the ANOVA comprising controls and patients with psychosis.
56-1	12526-12530	Only	_	
56-2	12531-12538	present	_	
56-3	12539-12541	in	_	
56-4	12542-12545	the	_	
56-5	12546-12551	ANOVA	_	
56-6	12552-12562	comprising	_	
56-7	12563-12571	controls	_	
56-8	12572-12575	and	_	
56-9	12576-12584	patients	_	
56-10	12585-12589	with	_	
56-11	12590-12599	psychosis	_	
56-12	12599-12600	.	_	

#Text=In terms of connectivity, we found the risk allele A was associated with decreased positive coupling between the left precentral gyrus/inferior frontal gyrus, pars opercularis seed (i.e. the most highly recruited area for the task) and: 1) the same region abovementioned under a genotype-by-diagnosis interaction [Z = 4.42; voxel-wise FWE-corrected p = 0.02 at a nearby white matter coordinate; ηp2(peak) = 4.33%; Fig. 1 - Part B]; and 2) the left posterior cingulate gyrus [Z = 4.34; voxel-wise FWE-corrected p = 0.03; ηp2(peak) = 7.60%], encompassing the precuneus; both as a main effect across controls and psychosis patients (Table 1).
57-1	12601-12603	In	_	
57-2	12604-12609	terms	_	
57-3	12610-12612	of	_	
57-4	12613-12625	connectivity	_	
57-5	12625-12626	,	_	
57-6	12627-12629	we	_	
57-7	12630-12635	found	_	
57-8	12636-12639	the	_	
57-9	12640-12644	risk	_	
57-10	12645-12651	allele	_	
57-11	12652-12653	A	_	
57-12	12654-12657	was	_	
57-13	12658-12668	associated	_	
57-14	12669-12673	with	_	
57-15	12674-12683	decreased	_	
57-16	12684-12692	positive	_	
57-17	12693-12701	coupling	_	
57-18	12702-12709	between	_	
57-19	12710-12713	the	_	
57-20	12714-12718	left	_	
57-21	12719-12729	precentral	_	
57-22	12730-12735	gyrus	_	
57-23	12735-12736	/	_	
57-24	12736-12744	inferior	_	
57-25	12745-12752	frontal	_	
57-26	12753-12758	gyrus	_	
57-27	12758-12759	,	_	
57-28	12760-12764	pars	_	
57-29	12765-12776	opercularis	_	
57-30	12777-12781	seed	_	
57-31	12782-12783	(	_	
57-32	12783-12786	i.e	_	
57-33	12786-12787	.	_	
57-34	12788-12791	the	_	
57-35	12792-12796	most	_	
57-36	12797-12803	highly	_	
57-37	12804-12813	recruited	_	
57-38	12814-12818	area	_	
57-39	12819-12822	for	_	
57-40	12823-12826	the	_	
57-41	12827-12831	task	_	
57-42	12831-12832	)	_	
57-43	12833-12836	and	_	
57-44	12836-12837	:	_	
57-45	12838-12839	1	_	
57-46	12839-12840	)	_	
57-47	12841-12844	the	_	
57-48	12845-12849	same	_	
57-49	12850-12856	region	_	
57-50	12857-12871	abovementioned	_	
57-51	12872-12877	under	_	
57-52	12878-12879	a	_	
57-53	12880-12901	genotype-by-diagnosis	_	
57-54	12902-12913	interaction	_	
57-55	12914-12915	[	_	
57-56	12915-12916	Z	_	
57-57	12916-12917	 	_	
57-58	12917-12918	=	_	
57-59	12918-12919	 	_	
57-60	12919-12923	4.42	_	
57-61	12923-12924	;	_	
57-62	12925-12935	voxel-wise	_	
57-63	12936-12949	FWE-corrected	_	
57-64	12950-12951	p	_	
57-65	12951-12952	 	_	
57-66	12952-12953	=	_	
57-67	12953-12954	 	_	
57-68	12954-12958	0.02	_	
57-69	12958-12959	 	_	
57-70	12959-12961	at	_	
57-71	12962-12963	a	_	
57-72	12964-12970	nearby	_	
57-73	12971-12976	white	_	
57-74	12977-12983	matter	_	
57-75	12984-12994	coordinate	_	
57-76	12994-12995	;	_	
57-77	12996-12999	ηp2	_	
57-78	12999-13000	(	_	
57-79	13000-13004	peak	_	
57-80	13004-13005	)	_	
57-81	13005-13006	 	_	
57-82	13006-13007	=	_	
57-83	13007-13008	 	_	
57-84	13008-13013	4.33%	_	
57-85	13013-13014	;	_	
57-86	13015-13018	Fig	_	
57-87	13018-13019	.	_	
57-88	13020-13021	1	_	
57-89	13022-13023	-	_	
57-90	13024-13028	Part	_	
57-91	13029-13030	B	_	
57-92	13030-13031	]	_	
57-93	13031-13032	;	_	
57-94	13033-13036	and	_	
57-95	13037-13038	2	_	
57-96	13038-13039	)	_	
57-97	13040-13043	the	_	
57-98	13044-13048	left	_	
57-99	13049-13058	posterior	_	
57-100	13059-13068	cingulate	_	
57-101	13069-13074	gyrus	_	
57-102	13075-13076	[	_	
57-103	13076-13077	Z	_	
57-104	13077-13078	 	_	
57-105	13078-13079	=	_	
57-106	13079-13080	 	_	
57-107	13080-13084	4.34	_	
57-108	13084-13085	;	_	
57-109	13086-13096	voxel-wise	_	
57-110	13097-13110	FWE-corrected	_	
57-111	13111-13112	p	_	
57-112	13112-13113	 	_	
57-113	13113-13114	=	_	
57-114	13114-13115	 	_	
57-115	13115-13119	0.03	_	
57-116	13119-13120	;	_	
57-117	13121-13124	ηp2	_	
57-118	13124-13125	(	_	
57-119	13125-13129	peak	_	
57-120	13129-13130	)	_	
57-121	13130-13131	 	_	
57-122	13131-13132	=	_	
57-123	13132-13133	 	_	
57-124	13133-13138	7.60%	_	
57-125	13138-13139	]	_	
57-126	13139-13140	,	_	
57-127	13141-13153	encompassing	_	
57-128	13154-13157	the	_	
57-129	13158-13167	precuneus	_	
57-130	13167-13168	;	_	
57-131	13169-13173	both	_	
57-132	13174-13176	as	_	
57-133	13177-13178	a	_	
57-134	13179-13183	main	_	
57-135	13184-13190	effect	_	
57-136	13191-13197	across	_	
57-137	13198-13206	controls	_	
57-138	13207-13210	and	_	
57-139	13211-13220	psychosis	_	
57-140	13221-13229	patients	_	
57-141	13230-13231	(	_	
57-142	13231-13236	Table	_	
57-143	13237-13238	1	_	
57-144	13238-13239	)	_	
57-145	13239-13240	.	_	

#Text=The latter effect in both areas was also present at FWE-corrected level when we only included SCZ and controls (and not present in BD alone at all, neither when we included the full BD group to the remaining groups) showing that these groups drove this main effect.
58-1	13241-13244	The	_	
58-2	13245-13251	latter	_	
58-3	13252-13258	effect	_	
58-4	13259-13261	in	_	
58-5	13262-13266	both	_	
58-6	13267-13272	areas	_	
58-7	13273-13276	was	_	
58-8	13277-13281	also	_	
58-9	13282-13289	present	_	
58-10	13290-13292	at	_	
58-11	13293-13306	FWE-corrected	_	
58-12	13307-13312	level	_	
58-13	13313-13317	when	_	
58-14	13318-13320	we	_	
58-15	13321-13325	only	_	
58-16	13326-13334	included	_	
58-17	13335-13338	SCZ	_	
58-18	13339-13342	and	_	
58-19	13343-13351	controls	_	
58-20	13352-13353	(	_	
58-21	13353-13356	and	_	
58-22	13357-13360	not	_	
58-23	13361-13368	present	_	
58-24	13369-13371	in	_	
58-25	13372-13374	BD	_	
58-26	13375-13380	alone	_	
58-27	13381-13383	at	_	
58-28	13384-13387	all	_	
58-29	13387-13388	,	_	
58-30	13389-13396	neither	_	
58-31	13397-13401	when	_	
58-32	13402-13404	we	_	
58-33	13405-13413	included	_	
58-34	13414-13417	the	_	
58-35	13418-13422	full	_	
58-36	13423-13425	BD	_	
58-37	13426-13431	group	_	
58-38	13432-13434	to	_	
58-39	13435-13438	the	_	
58-40	13439-13448	remaining	_	
58-41	13449-13455	groups	_	
58-42	13455-13456	)	_	
58-43	13457-13464	showing	_	
58-44	13465-13469	that	_	
58-45	13470-13475	these	_	
58-46	13476-13482	groups	_	
58-47	13483-13488	drove	_	
58-48	13489-13493	this	_	
58-49	13494-13498	main	_	
58-50	13499-13505	effect	_	
58-51	13505-13506	.	_	

#Text=In neither ANOVA models (with or without non-psychotic BD), did we find significant interaction effects.
59-1	13507-13509	In	_	
59-2	13510-13517	neither	_	
59-3	13518-13523	ANOVA	_	
59-4	13524-13530	models	_	
59-5	13531-13532	(	_	
59-6	13532-13536	with	_	
59-7	13537-13539	or	_	
59-8	13540-13547	without	_	
59-9	13548-13561	non-psychotic	_	
59-10	13562-13564	BD	_	
59-11	13564-13565	)	_	
59-12	13565-13566	,	_	
59-13	13567-13570	did	_	
59-14	13571-13573	we	_	
59-15	13574-13578	find	_	
59-16	13579-13590	significant	_	
59-17	13591-13602	interaction	_	
59-18	13603-13610	effects	_	
59-19	13610-13611	.	_	

#Text=(Although unexpected, we note that white matter BOLD signals in a wide-variety of brain areas, task - or even resting-state-based fMRI have been extensively reported – and we have reported lower white matter fractional anisotropy, a putative proxy of integrity, to be widely associated with this polymorphism).
60-1	13612-13613	(	_	
60-2	13613-13621	Although	_	
60-3	13622-13632	unexpected	_	
60-4	13632-13633	,	_	
60-5	13634-13636	we	_	
60-6	13637-13641	note	_	
60-7	13642-13646	that	_	
60-8	13647-13652	white	_	
60-9	13653-13659	matter	_	
60-10	13660-13664	BOLD	_	
60-11	13665-13672	signals	_	
60-12	13673-13675	in	_	
60-13	13676-13677	a	_	
60-14	13678-13690	wide-variety	_	
60-15	13691-13693	of	_	
60-16	13694-13699	brain	_	
60-17	13700-13705	areas	_	
60-18	13705-13706	,	_	
60-19	13707-13711	task	_	
60-20	13712-13713	-	_	
60-21	13714-13716	or	_	
60-22	13717-13721	even	_	
60-23	13722-13741	resting-state-based	_	
60-24	13742-13746	fMRI	_	
60-25	13747-13751	have	_	
60-26	13752-13756	been	_	
60-27	13757-13768	extensively	_	
60-28	13769-13777	reported	_	
60-29	13778-13779	–	_	
60-30	13780-13783	and	_	
60-31	13784-13786	we	_	
60-32	13787-13791	have	_	
60-33	13792-13800	reported	_	
60-34	13801-13806	lower	_	
60-35	13807-13812	white	_	
60-36	13813-13819	matter	_	
60-37	13820-13830	fractional	_	
60-38	13831-13841	anisotropy	_	
60-39	13841-13842	,	_	
60-40	13843-13844	a	_	
60-41	13845-13853	putative	_	
60-42	13854-13859	proxy	_	
60-43	13860-13862	of	_	
60-44	13863-13872	integrity	_	
60-45	13872-13873	,	_	
60-46	13874-13876	to	_	
60-47	13877-13879	be	_	
60-48	13880-13886	widely	_	
60-49	13887-13897	associated	_	
60-50	13898-13902	with	_	
60-51	13903-13907	this	_	
60-52	13908-13920	polymorphism	_	
60-53	13920-13921	)	_	
60-54	13921-13922	.	_	

#Text=Importantly, we found no area (even at a trend level of uncorrected p < 0.001) that showed to be under the opposite main effect (i.e. higher functional connectivity correlated with the risk allele A).
61-1	13923-13934	Importantly	_	
61-2	13934-13935	,	_	
61-3	13936-13938	we	_	
61-4	13939-13944	found	_	
61-5	13945-13947	no	_	
61-6	13948-13952	area	_	
61-7	13953-13954	(	_	
61-8	13954-13958	even	_	
61-9	13959-13961	at	_	
61-10	13962-13963	a	_	
61-11	13964-13969	trend	_	
61-12	13970-13975	level	_	
61-13	13976-13978	of	_	
61-14	13979-13990	uncorrected	_	
61-15	13991-13992	p	_	
61-16	13992-13993	 	_	
61-17	13993-13994	<	_	
61-18	13994-13995	 	_	
61-19	13995-14000	0.001	_	
61-20	14000-14001	)	_	
61-21	14002-14006	that	_	
61-22	14007-14013	showed	_	
61-23	14014-14016	to	_	
61-24	14017-14019	be	_	
61-25	14020-14025	under	_	
61-26	14026-14029	the	_	
61-27	14030-14038	opposite	_	
61-28	14039-14043	main	_	
61-29	14044-14050	effect	_	
61-30	14051-14052	(	_	
61-31	14052-14055	i.e	_	
61-32	14055-14056	.	_	
61-33	14057-14063	higher	_	
61-34	14064-14074	functional	_	
61-35	14075-14087	connectivity	_	
61-36	14088-14098	correlated	_	
61-37	14099-14103	with	_	
61-38	14104-14107	the	_	
61-39	14108-14112	risk	_	
61-40	14113-14119	allele	_	
61-41	14120-14121	A	_	
61-42	14121-14122	)	_	
61-43	14122-14123	.	_	

#Text=Like the present findings in verbal fluency, studies have shown intra- (and also inter-) hemispheric prefrontal connectivity decrease, in working memory, facial emotion recognition and resting state – which was replicated by others, albeit not always.
62-1	14124-14128	Like	_	
62-2	14129-14132	the	_	
62-3	14133-14140	present	_	
62-4	14141-14149	findings	_	
62-5	14150-14152	in	_	
62-6	14153-14159	verbal	_	
62-7	14160-14167	fluency	_	
62-8	14167-14168	,	_	
62-9	14169-14176	studies	_	
62-10	14177-14181	have	_	
62-11	14182-14187	shown	_	
62-12	14188-14193	intra	_	
62-13	14193-14194	-	_	
62-14	14195-14196	(	_	
62-15	14196-14199	and	_	
62-16	14200-14204	also	_	
62-17	14205-14210	inter	_	
62-18	14210-14211	-	_	
62-19	14211-14212	)	_	
62-20	14213-14224	hemispheric	_	
62-21	14225-14235	prefrontal	_	
62-22	14236-14248	connectivity	_	
62-23	14249-14257	decrease	_	
62-24	14257-14258	,	_	
62-25	14259-14261	in	_	
62-26	14262-14269	working	_	
62-27	14270-14276	memory	_	
62-28	14276-14277	,	_	
62-29	14278-14284	facial	_	
62-30	14285-14292	emotion	_	
62-31	14293-14304	recognition	_	
62-32	14305-14308	and	_	
62-33	14309-14316	resting	_	
62-34	14317-14322	state	_	
62-35	14323-14324	–	_	
62-36	14325-14330	which	_	
62-37	14331-14334	was	_	
62-38	14335-14345	replicated	_	
62-39	14346-14348	by	_	
62-40	14349-14355	others	_	
62-41	14355-14356	,	_	
62-42	14357-14363	albeit	_	
62-43	14364-14367	not	_	
62-44	14368-14374	always	_	
62-45	14374-14375	.	_	

#Text=(Interestingly, in SCZ, the risk allele has been associated with increased functional connectivity within the right prefrontal cortex, as opposed to the abovementioned literature in health – alerting to putative genotype-by-diagnosis interactions.)
63-1	14376-14377	(	_	
63-2	14377-14390	Interestingly	_	
63-3	14390-14391	,	_	
63-4	14392-14394	in	_	
63-5	14395-14398	SCZ	_	
63-6	14398-14399	,	_	
63-7	14400-14403	the	_	
63-8	14404-14408	risk	_	
63-9	14409-14415	allele	_	
63-10	14416-14419	has	_	
63-11	14420-14424	been	_	
63-12	14425-14435	associated	_	
63-13	14436-14440	with	_	
63-14	14441-14450	increased	_	
63-15	14451-14461	functional	_	
63-16	14462-14474	connectivity	_	
63-17	14475-14481	within	_	
63-18	14482-14485	the	_	
63-19	14486-14491	right	_	
63-20	14492-14502	prefrontal	_	
63-21	14503-14509	cortex	_	
63-22	14509-14510	,	_	
63-23	14511-14513	as	_	
63-24	14514-14521	opposed	_	
63-25	14522-14524	to	_	
63-26	14525-14528	the	_	
63-27	14529-14543	abovementioned	_	
63-28	14544-14554	literature	_	
63-29	14555-14557	in	_	
63-30	14558-14564	health	_	
63-31	14565-14566	–	_	
63-32	14567-14575	alerting	_	
63-33	14576-14578	to	_	
63-34	14579-14587	putative	_	
63-35	14588-14609	genotype-by-diagnosis	_	
63-36	14610-14622	interactions	_	
63-37	14622-14623	.	_	
63-38	14623-14624	)	_	

#Text=In fact, decreased prefrontal intra- and inter-hemispheric connectivity associated with this (SCZ) risk allele is consistent with the dysconnectivity hypothesis of SCZ, which has been especially supported between the hemispheres.
64-1	14625-14627	In	_	
64-2	14628-14632	fact	_	
64-3	14632-14633	,	_	
64-4	14634-14643	decreased	_	
64-5	14644-14654	prefrontal	_	
64-6	14655-14660	intra	_	
64-7	14660-14661	-	_	
64-8	14662-14665	and	_	
64-9	14666-14683	inter-hemispheric	_	
64-10	14684-14696	connectivity	_	
64-11	14697-14707	associated	_	
64-12	14708-14712	with	_	
64-13	14713-14717	this	_	
64-14	14718-14719	(	_	
64-15	14719-14722	SCZ	_	
64-16	14722-14723	)	_	
64-17	14724-14728	risk	_	
64-18	14729-14735	allele	_	
64-19	14736-14738	is	_	
64-20	14739-14749	consistent	_	
64-21	14750-14754	with	_	
64-22	14755-14758	the	_	
64-23	14759-14774	dysconnectivity	_	
64-24	14775-14785	hypothesis	_	
64-25	14786-14788	of	_	
64-26	14789-14792	SCZ	_	
64-27	14792-14793	,	_	
64-28	14794-14799	which	_	
64-29	14800-14803	has	_	
64-30	14804-14808	been	_	
64-31	14809-14819	especially	_	
64-32	14820-14829	supported	_	
64-33	14830-14837	between	_	
64-34	14838-14841	the	_	
64-35	14842-14853	hemispheres	_	
64-36	14853-14854	.	_	

#Text=Another main finding in the literature is an association of the risk allele, during working memory, with increased functional connectivity between the right dorsolateral prefrontal cortex and the left hippocampal formation in health.
65-1	14855-14862	Another	_	
65-2	14863-14867	main	_	
65-3	14868-14875	finding	_	
65-4	14876-14878	in	_	
65-5	14879-14882	the	_	
65-6	14883-14893	literature	_	
65-7	14894-14896	is	_	
65-8	14897-14899	an	_	
65-9	14900-14911	association	_	
65-10	14912-14914	of	_	
65-11	14915-14918	the	_	
65-12	14919-14923	risk	_	
65-13	14924-14930	allele	_	
65-14	14930-14931	,	_	
65-15	14932-14938	during	_	
65-16	14939-14946	working	_	
65-17	14947-14953	memory	_	
65-18	14953-14954	,	_	
65-19	14955-14959	with	_	
65-20	14960-14969	increased	_	
65-21	14970-14980	functional	_	
65-22	14981-14993	connectivity	_	
65-23	14994-15001	between	_	
65-24	15002-15005	the	_	
65-25	15006-15011	right	_	
65-26	15012-15024	dorsolateral	_	
65-27	15025-15035	prefrontal	_	
65-28	15036-15042	cortex	_	
65-29	15043-15046	and	_	
65-30	15047-15050	the	_	
65-31	15051-15055	left	_	
65-32	15056-15067	hippocampal	_	
65-33	15068-15077	formation	_	
65-34	15078-15080	in	_	
65-35	15081-15087	health	_	
65-36	15087-15088	.	_	

#Text=(This has been replicated in Han Chinese and as a trend in another study but not by another report of decreased coupling and yet another of decreased coupling between left hippocampal formation, this time with the posterior cingulate cortex.
66-1	15089-15090	(	_	
66-2	15090-15094	This	_	
66-3	15095-15098	has	_	
66-4	15099-15103	been	_	
66-5	15104-15114	replicated	_	
66-6	15115-15117	in	_	
66-7	15118-15121	Han	_	
66-8	15122-15129	Chinese	_	
66-9	15130-15133	and	_	
66-10	15134-15136	as	_	
66-11	15137-15138	a	_	
66-12	15139-15144	trend	_	
66-13	15145-15147	in	_	
66-14	15148-15155	another	_	
66-15	15156-15161	study	_	
66-16	15162-15165	but	_	
66-17	15166-15169	not	_	
66-18	15170-15172	by	_	
66-19	15173-15180	another	_	
66-20	15181-15187	report	_	
66-21	15188-15190	of	_	
66-22	15191-15200	decreased	_	
66-23	15201-15209	coupling	_	
66-24	15210-15213	and	_	
66-25	15214-15217	yet	_	
66-26	15218-15225	another	_	
66-27	15226-15228	of	_	
66-28	15229-15238	decreased	_	
66-29	15239-15247	coupling	_	
66-30	15248-15255	between	_	
66-31	15256-15260	left	_	
66-32	15261-15272	hippocampal	_	
66-33	15273-15282	formation	_	
66-34	15282-15283	,	_	
66-35	15284-15288	this	_	
66-36	15289-15293	time	_	
66-37	15294-15298	with	_	
66-38	15299-15302	the	_	
66-39	15303-15312	posterior	_	
66-40	15313-15322	cingulate	_	
66-41	15323-15329	cortex	_	
66-42	15329-15330	.	_	

#Text=This prefrontal-hippocampal effect was concluded to be task-specific since it was not verified in facial emotion recognition or resting state tasks in the same sample - which likely explains why we have not replicated it in verbal fluency.
67-1	15331-15335	This	_	
67-2	15336-15358	prefrontal-hippocampal	_	
67-3	15359-15365	effect	_	
67-4	15366-15369	was	_	
67-5	15370-15379	concluded	_	
67-6	15380-15382	to	_	
67-7	15383-15385	be	_	
67-8	15386-15399	task-specific	_	
67-9	15400-15405	since	_	
67-10	15406-15408	it	_	
67-11	15409-15412	was	_	
67-12	15413-15416	not	_	
67-13	15417-15425	verified	_	
67-14	15426-15428	in	_	
67-15	15429-15435	facial	_	
67-16	15436-15443	emotion	_	
67-17	15444-15455	recognition	_	
67-18	15456-15458	or	_	
67-19	15459-15466	resting	_	
67-20	15467-15472	state	_	
67-21	15473-15478	tasks	_	
67-22	15479-15481	in	_	
67-23	15482-15485	the	_	
67-24	15486-15490	same	_	
67-25	15491-15497	sample	_	
67-26	15498-15499	-	_	
67-27	15500-15505	which	_	
67-28	15506-15512	likely	_	
67-29	15513-15521	explains	_	
67-30	15522-15525	why	_	
67-31	15526-15528	we	_	
67-32	15529-15533	have	_	
67-33	15534-15537	not	_	
67-34	15538-15548	replicated	_	
67-35	15549-15551	it	_	
67-36	15552-15554	in	_	
67-37	15555-15561	verbal	_	
67-38	15562-15569	fluency	_	
67-39	15569-15570	.	_	

#Text=In terms of PPI connectivity, we found no statistically significant (FWE p < 0.05) main effect of genotype or genotype-by-diagnosis interactions.
68-1	15571-15573	In	_	
68-2	15574-15579	terms	_	
68-3	15580-15582	of	_	
68-4	15583-15586	PPI	_	
68-5	15587-15599	connectivity	_	
68-6	15599-15600	,	_	
68-7	15601-15603	we	_	
68-8	15604-15609	found	_	
68-9	15610-15612	no	_	
68-10	15613-15626	statistically	_	
68-11	15627-15638	significant	_	
68-12	15639-15640	(	_	
68-13	15640-15643	FWE	_	
68-14	15644-15645	p	_	
68-15	15645-15646	 	_	
68-16	15646-15647	<	_	
68-17	15647-15648	 	_	
68-18	15648-15652	0.05	_	
68-19	15652-15653	)	_	
68-20	15654-15658	main	_	
68-21	15659-15665	effect	_	
68-22	15666-15668	of	_	
68-23	15669-15677	genotype	_	
68-24	15678-15680	or	_	
68-25	15681-15702	genotype-by-diagnosis	_	
68-26	15703-15715	interactions	_	
68-27	15715-15716	.	_	

#Text=Moreover, these findings lend support to, and, in fact, are likely explained by, our recent results in an overlapping sample, of a widespread and significant decrease in microstructural white matter fractional anisotropy, a putative proxy of white matter integrity, via diffusion tensor MRI, associated to this same risk variant (allele A).
69-1	15717-15725	Moreover	_	
69-2	15725-15726	,	_	
69-3	15727-15732	these	_	
69-4	15733-15741	findings	_	
69-5	15742-15746	lend	_	
69-6	15747-15754	support	_	
69-7	15755-15757	to	_	
69-8	15757-15758	,	_	
69-9	15759-15762	and	_	
69-10	15762-15763	,	_	
69-11	15764-15766	in	_	
69-12	15767-15771	fact	_	
69-13	15771-15772	,	_	
69-14	15773-15776	are	_	
69-15	15777-15783	likely	_	
69-16	15784-15793	explained	_	
69-17	15794-15796	by	_	
69-18	15796-15797	,	_	
69-19	15798-15801	our	_	
69-20	15802-15808	recent	_	
69-21	15809-15816	results	_	
69-22	15817-15819	in	_	
69-23	15820-15822	an	_	
69-24	15823-15834	overlapping	_	
69-25	15835-15841	sample	_	
69-26	15841-15842	,	_	
69-27	15843-15845	of	_	
69-28	15846-15847	a	_	
69-29	15848-15858	widespread	_	
69-30	15859-15862	and	_	
69-31	15863-15874	significant	_	
69-32	15875-15883	decrease	_	
69-33	15884-15886	in	_	
69-34	15887-15902	microstructural	_	
69-35	15903-15908	white	_	
69-36	15909-15915	matter	_	
69-37	15916-15926	fractional	_	
69-38	15927-15937	anisotropy	_	
69-39	15937-15938	,	_	
69-40	15939-15940	a	_	
69-41	15941-15949	putative	_	
69-42	15950-15955	proxy	_	
69-43	15956-15958	of	_	
69-44	15959-15964	white	_	
69-45	15965-15971	matter	_	
69-46	15972-15981	integrity	_	
69-47	15981-15982	,	_	
69-48	15983-15986	via	_	
69-49	15987-15996	diffusion	_	
69-50	15997-16003	tensor	_	
69-51	16004-16007	MRI	_	
69-52	16007-16008	,	_	
69-53	16009-16019	associated	_	
69-54	16020-16022	to	_	
69-55	16023-16027	this	_	
69-56	16028-16032	same	_	
69-57	16033-16037	risk	_	
69-58	16038-16045	variant	_	
69-59	16046-16047	(	_	
69-60	16047-16053	allele	_	
69-61	16054-16055	A	_	
69-62	16055-16056	)	_	
69-63	16056-16057	.	_	

#Text=Importantly, nowhere in the brain (at a trend level) did we find evidence for an association of this risk allele with the opposite effect we report in that study, i.e. of higher microstructural white matter integrity.
70-1	16058-16069	Importantly	_	
70-2	16069-16070	,	_	
70-3	16071-16078	nowhere	_	
70-4	16079-16081	in	_	
70-5	16082-16085	the	_	
70-6	16086-16091	brain	_	
70-7	16092-16093	(	_	
70-8	16093-16095	at	_	
70-9	16096-16097	a	_	
70-10	16098-16103	trend	_	
70-11	16104-16109	level	_	
70-12	16109-16110	)	_	
70-13	16111-16114	did	_	
70-14	16115-16117	we	_	
70-15	16118-16122	find	_	
70-16	16123-16131	evidence	_	
70-17	16132-16135	for	_	
70-18	16136-16138	an	_	
70-19	16139-16150	association	_	
70-20	16151-16153	of	_	
70-21	16154-16158	this	_	
70-22	16159-16163	risk	_	
70-23	16164-16170	allele	_	
70-24	16171-16175	with	_	
70-25	16176-16179	the	_	
70-26	16180-16188	opposite	_	
70-27	16189-16195	effect	_	
70-28	16196-16198	we	_	
70-29	16199-16205	report	_	
70-30	16206-16208	in	_	
70-31	16209-16213	that	_	
70-32	16214-16219	study	_	
70-33	16219-16220	,	_	
70-34	16221-16224	i.e	_	
70-35	16224-16225	.	_	
70-36	16226-16228	of	_	
70-37	16229-16235	higher	_	
70-38	16236-16251	microstructural	_	
70-39	16252-16257	white	_	
70-40	16258-16264	matter	_	
70-41	16265-16274	integrity	_	
70-42	16274-16275	.	_	

#Text=We thus provide evidence that supports the dysconnectivity hypothesis of SCZ, and a contributing role of rs1344706 risk allele, and extend its impact from the previously reported in working memory and emotional paradigms, to verbal fluency for the first time.
71-1	16276-16278	We	_	
71-2	16279-16283	thus	_	
71-3	16284-16291	provide	_	
71-4	16292-16300	evidence	_	
71-5	16301-16305	that	_	
71-6	16306-16314	supports	_	
71-7	16315-16318	the	_	
71-8	16319-16334	dysconnectivity	_	
71-9	16335-16345	hypothesis	_	
71-10	16346-16348	of	_	
71-11	16349-16352	SCZ	_	
71-12	16352-16353	,	_	
71-13	16354-16357	and	_	
71-14	16358-16359	a	_	
71-15	16360-16372	contributing	_	
71-16	16373-16377	role	_	
71-17	16378-16380	of	_	
71-18	16381-16390	rs1344706	_	
71-19	16391-16395	risk	_	
71-20	16396-16402	allele	_	
71-21	16402-16403	,	_	
71-22	16404-16407	and	_	
71-23	16408-16414	extend	_	
71-24	16415-16418	its	_	
71-25	16419-16425	impact	_	
71-26	16426-16430	from	_	
71-27	16431-16434	the	_	
71-28	16435-16445	previously	_	
71-29	16446-16454	reported	_	
71-30	16455-16457	in	_	
71-31	16458-16465	working	_	
71-32	16466-16472	memory	_	
71-33	16473-16476	and	_	
71-34	16477-16486	emotional	_	
71-35	16487-16496	paradigms	_	
71-36	16496-16497	,	_	
71-37	16498-16500	to	_	
71-38	16501-16507	verbal	_	
71-39	16508-16515	fluency	_	
71-40	16516-16519	for	_	
71-41	16520-16523	the	_	
71-42	16524-16529	first	_	
71-43	16530-16534	time	_	
71-44	16534-16535	.	_	

#Text=Potential confounding factors
#Text=As none of our demographic or medication variables correlated with genotype, they are unlikely to be confounding variables.
72-1	16536-16545	Potential	_	
72-2	16546-16557	confounding	_	
72-3	16558-16565	factors	_	
72-4	16566-16568	As	_	
72-5	16569-16573	none	_	
72-6	16574-16576	of	_	
72-7	16577-16580	our	_	
72-8	16581-16592	demographic	_	
72-9	16593-16595	or	_	
72-10	16596-16606	medication	_	
72-11	16607-16616	variables	_	
72-12	16617-16627	correlated	_	
72-13	16628-16632	with	_	
72-14	16633-16641	genotype	_	
72-15	16641-16642	,	_	
72-16	16643-16647	they	_	
72-17	16648-16651	are	_	
72-18	16652-16660	unlikely	_	
72-19	16661-16663	to	_	
72-20	16664-16666	be	_	
72-21	16667-16678	confounding	_	
72-22	16679-16688	variables	_	
72-23	16688-16689	.	_	

#Text=In addition, we found no variable to affect brain activation in areas that we report to be under a genotype effect.
73-1	16690-16692	In	_	
73-2	16693-16701	addition	_	
73-3	16701-16702	,	_	
73-4	16703-16705	we	_	
73-5	16706-16711	found	_	
73-6	16712-16714	no	_	
73-7	16715-16723	variable	_	
73-8	16724-16726	to	_	
73-9	16727-16733	affect	_	
73-10	16734-16739	brain	_	
73-11	16740-16750	activation	_	
73-12	16751-16753	in	_	
73-13	16754-16759	areas	_	
73-14	16760-16764	that	_	
73-15	16765-16767	we	_	
73-16	16768-16774	report	_	
73-17	16775-16777	to	_	
73-18	16778-16780	be	_	
73-19	16781-16786	under	_	
73-20	16787-16788	a	_	
73-21	16789-16797	genotype	_	
73-22	16798-16804	effect	_	
73-23	16804-16805	.	_	

#Text=We also found no relevant change in effect size or foci of activation of genotype effects when these variables were introduced in the ANOVA.
74-1	16806-16808	We	_	
74-2	16809-16813	also	_	
74-3	16814-16819	found	_	
74-4	16820-16822	no	_	
74-5	16823-16831	relevant	_	
74-6	16832-16838	change	_	
74-7	16839-16841	in	_	
74-8	16842-16848	effect	_	
74-9	16849-16853	size	_	
74-10	16854-16856	or	_	
74-11	16857-16861	foci	_	
74-12	16862-16864	of	_	
74-13	16865-16875	activation	_	
74-14	16876-16878	of	_	
74-15	16879-16887	genotype	_	
74-16	16888-16895	effects	_	
74-17	16896-16900	when	_	
74-18	16901-16906	these	_	
74-19	16907-16916	variables	_	
74-20	16917-16921	were	_	
74-21	16922-16932	introduced	_	
74-22	16933-16935	in	_	
74-23	16936-16939	the	_	
74-24	16940-16945	ANOVA	_	
74-25	16945-16946	.	_	

#Text=Thirdly, no variable correlated with the peak activation values retrieved from our genotype effect analyses.
75-1	16947-16954	Thirdly	_	
75-2	16954-16955	,	_	
75-3	16956-16958	no	_	
75-4	16959-16967	variable	_	
75-5	16968-16978	correlated	_	
75-6	16979-16983	with	_	
75-7	16984-16987	the	_	
75-8	16988-16992	peak	_	
75-9	16993-17003	activation	_	
75-10	17004-17010	values	_	
75-11	17011-17020	retrieved	_	
75-12	17021-17025	from	_	
75-13	17026-17029	our	_	
75-14	17030-17038	genotype	_	
75-15	17039-17045	effect	_	
75-16	17046-17054	analyses	_	
75-17	17054-17055	.	_	

#Text=Complementary gene expression analyses
#Text=For complementary information, we searched a publicly available online database to determine whether the risk allele (or, rather, the linkage disequilibrium block it tags) affected ZNF804A mRNA expression level in any of the available 10 brain areas (i.e. was a cis-eQTL).
76-1	17056-17069	Complementary	_	
76-2	17070-17074	gene	_	
76-3	17075-17085	expression	_	
76-4	17086-17094	analyses	_	
76-5	17095-17098	For	_	
76-6	17099-17112	complementary	_	
76-7	17113-17124	information	_	
76-8	17124-17125	,	_	
76-9	17126-17128	we	_	
76-10	17129-17137	searched	_	
76-11	17138-17139	a	_	
76-12	17140-17148	publicly	_	
76-13	17149-17158	available	_	
76-14	17159-17165	online	_	
76-15	17166-17174	database	_	
76-16	17175-17177	to	_	
76-17	17178-17187	determine	_	
76-18	17188-17195	whether	_	
76-19	17196-17199	the	_	
76-20	17200-17204	risk	_	
76-21	17205-17211	allele	_	
76-22	17212-17213	(	_	
76-23	17213-17215	or	_	
76-24	17215-17216	,	_	
76-25	17217-17223	rather	_	
76-26	17223-17224	,	_	
76-27	17225-17228	the	_	
76-28	17229-17236	linkage	_	
76-29	17237-17251	disequilibrium	_	
76-30	17252-17257	block	_	
76-31	17258-17260	it	_	
76-32	17261-17265	tags	_	
76-33	17265-17266	)	_	
76-34	17267-17275	affected	_	
76-35	17276-17283	ZNF804A	_	
76-36	17284-17288	mRNA	_	
76-37	17289-17299	expression	_	
76-38	17300-17305	level	_	
76-39	17306-17308	in	_	
76-40	17309-17312	any	_	
76-41	17313-17315	of	_	
76-42	17316-17319	the	_	
76-43	17320-17329	available	_	
76-44	17330-17332	10	_	
76-45	17333-17338	brain	_	
76-46	17339-17344	areas	_	
76-47	17345-17346	(	_	
76-48	17346-17349	i.e	_	
76-49	17349-17350	.	_	
76-50	17351-17354	was	_	
76-51	17355-17356	a	_	
76-52	17357-17365	cis-eQTL	_	
76-53	17365-17366	)	_	
76-54	17366-17367	.	_	

#Text=We found the rs1344706 risk allele to be associated (at p < 0.05, uncorrected for brain areas) with increased ZNF804A exonic transcription levels in the hippocampus, medulla oblongata and occipital cortex (details in Supplement 4).
77-1	17368-17370	We	_	
77-2	17371-17376	found	_	
77-3	17377-17380	the	_	
77-4	17381-17390	rs1344706	_	
77-5	17391-17395	risk	_	
77-6	17396-17402	allele	_	
77-7	17403-17405	to	_	
77-8	17406-17408	be	_	
77-9	17409-17419	associated	_	
77-10	17420-17421	(	_	
77-11	17421-17423	at	_	
77-12	17424-17425	p	_	
77-13	17425-17426	 	_	
77-14	17426-17427	<	_	
77-15	17427-17428	 	_	
77-16	17428-17432	0.05	_	
77-17	17432-17433	,	_	
77-18	17434-17445	uncorrected	_	
77-19	17446-17449	for	_	
77-20	17450-17455	brain	_	
77-21	17456-17461	areas	_	
77-22	17461-17462	)	_	
77-23	17463-17467	with	_	
77-24	17468-17477	increased	_	
77-25	17478-17485	ZNF804A	_	
77-26	17486-17492	exonic	_	
77-27	17493-17506	transcription	_	
77-28	17507-17513	levels	_	
77-29	17514-17516	in	_	
77-30	17517-17520	the	_	
77-31	17521-17532	hippocampus	_	
77-32	17532-17533	,	_	
77-33	17534-17541	medulla	_	
77-34	17542-17551	oblongata	_	
77-35	17552-17555	and	_	
77-36	17556-17565	occipital	_	
77-37	17566-17572	cortex	_	
77-38	17573-17574	(	_	
77-39	17574-17581	details	_	
77-40	17582-17584	in	_	
77-41	17585-17595	Supplement	_	
77-42	17596-17597	4	_	
77-43	17597-17598	)	_	
77-44	17598-17599	.	_	

#Text=For completeness, we also provide an analysis of Allen Brain Atlas data to define maps of ZNF804A expression in the human brain: relatively ZNF804A-enriched areas (mean normalized Z-score >1; details in Supplement 5) were the bed nucleus of stria terminalis, the nucleus of the diagonal band, the olfactory tubercle, the septal nuclei, the claustrum, the medial habenula, the hippocampal formation, the hypothalamus and the oculomotor and cochlear nuclei.
78-1	17600-17603	For	_	
78-2	17604-17616	completeness	_	
78-3	17616-17617	,	_	
78-4	17618-17620	we	_	
78-5	17621-17625	also	_	
78-6	17626-17633	provide	_	
78-7	17634-17636	an	_	
78-8	17637-17645	analysis	_	
78-9	17646-17648	of	_	
78-10	17649-17654	Allen	_	
78-11	17655-17660	Brain	_	
78-12	17661-17666	Atlas	_	
78-13	17667-17671	data	_	
78-14	17672-17674	to	_	
78-15	17675-17681	define	_	
78-16	17682-17686	maps	_	
78-17	17687-17689	of	_	
78-18	17690-17697	ZNF804A	_	
78-19	17698-17708	expression	_	
78-20	17709-17711	in	_	
78-21	17712-17715	the	_	
78-22	17716-17721	human	_	
78-23	17722-17727	brain	_	
78-24	17727-17728	:	_	
78-25	17729-17739	relatively	_	
78-26	17740-17756	ZNF804A-enriched	_	
78-27	17757-17762	areas	_	
78-28	17763-17764	(	_	
78-29	17764-17768	mean	_	
78-30	17769-17779	normalized	_	
78-31	17780-17787	Z-score	_	
78-32	17788-17789	>	_	
78-33	17789-17790	1	_	
78-34	17790-17791	;	_	
78-35	17792-17799	details	_	
78-36	17800-17802	in	_	
78-37	17803-17813	Supplement	_	
78-38	17814-17815	5	_	
78-39	17815-17816	)	_	
78-40	17817-17821	were	_	
78-41	17822-17825	the	_	
78-42	17826-17829	bed	_	
78-43	17830-17837	nucleus	_	
78-44	17838-17840	of	_	
78-45	17841-17846	stria	_	
78-46	17847-17857	terminalis	_	
78-47	17857-17858	,	_	
78-48	17859-17862	the	_	
78-49	17863-17870	nucleus	_	
78-50	17871-17873	of	_	
78-51	17874-17877	the	_	
78-52	17878-17886	diagonal	_	
78-53	17887-17891	band	_	
78-54	17891-17892	,	_	
78-55	17893-17896	the	_	
78-56	17897-17906	olfactory	_	
78-57	17907-17915	tubercle	_	
78-58	17915-17916	,	_	
78-59	17917-17920	the	_	
78-60	17921-17927	septal	_	
78-61	17928-17934	nuclei	_	
78-62	17934-17935	,	_	
78-63	17936-17939	the	_	
78-64	17940-17949	claustrum	_	
78-65	17949-17950	,	_	
78-66	17951-17954	the	_	
78-67	17955-17961	medial	_	
78-68	17962-17970	habenula	_	
78-69	17970-17971	,	_	
78-70	17972-17975	the	_	
78-71	17976-17987	hippocampal	_	
78-72	17988-17997	formation	_	
78-73	17997-17998	,	_	
78-74	17999-18002	the	_	
78-75	18003-18015	hypothalamus	_	
78-76	18016-18019	and	_	
78-77	18020-18023	the	_	
78-78	18024-18034	oculomotor	_	
78-79	18035-18038	and	_	
78-80	18039-18047	cochlear	_	
78-81	18048-18054	nuclei	_	
78-82	18054-18055	.	_	

#Text=Of note, from both these analyses the hippocampus was one of the areas where we found, at uncorrected p < 0.001, a main effect of genotype on functional connectivity with the seed (of the main effect of task) during verbal fluency.
79-1	18056-18058	Of	_	
79-2	18059-18063	note	_	
79-3	18063-18064	,	_	
79-4	18065-18069	from	_	
79-5	18070-18074	both	_	
79-6	18075-18080	these	_	
79-7	18081-18089	analyses	_	
79-8	18090-18093	the	_	
79-9	18094-18105	hippocampus	_	
79-10	18106-18109	was	_	
79-11	18110-18113	one	_	
79-12	18114-18116	of	_	
79-13	18117-18120	the	_	
79-14	18121-18126	areas	_	
79-15	18127-18132	where	_	
79-16	18133-18135	we	_	
79-17	18136-18141	found	_	
79-18	18141-18142	,	_	
79-19	18143-18145	at	_	
79-20	18146-18157	uncorrected	_	
79-21	18158-18159	p	_	
79-22	18159-18160	 	_	
79-23	18160-18161	<	_	
79-24	18161-18162	 	_	
79-25	18162-18167	0.001	_	
79-26	18167-18168	,	_	
79-27	18169-18170	a	_	
79-28	18171-18175	main	_	
79-29	18176-18182	effect	_	
79-30	18183-18185	of	_	
79-31	18186-18194	genotype	_	
79-32	18195-18197	on	_	
79-33	18198-18208	functional	_	
79-34	18209-18221	connectivity	_	
79-35	18222-18226	with	_	
79-36	18227-18230	the	_	
79-37	18231-18235	seed	_	
79-38	18236-18237	(	_	
79-39	18237-18239	of	_	
79-40	18240-18243	the	_	
79-41	18244-18248	main	_	
79-42	18249-18255	effect	_	
79-43	18256-18258	of	_	
79-44	18259-18263	task	_	
79-45	18263-18264	)	_	
79-46	18265-18271	during	_	
79-47	18272-18278	verbal	_	
79-48	18279-18286	fluency	_	
79-49	18286-18287	.	_	

#Text=Conclusion
#Text=In summary, we report statistically significant associations between genome-wide psychosis-implicated ZNF804A rs1344706 risk allele in a genotype-by-BD-diagnosis interaction on regional activation, and across psychosis patients and healthy samples with decreased functional connectivity, during verbal fluency – a task engaging brain regions and cognitive processes impaired in SCZ and BD.
80-1	18288-18298	Conclusion	_	
80-2	18299-18301	In	_	
80-3	18302-18309	summary	_	
80-4	18309-18310	,	_	
80-5	18311-18313	we	_	
80-6	18314-18320	report	_	
80-7	18321-18334	statistically	_	
80-8	18335-18346	significant	_	
80-9	18347-18359	associations	_	
80-10	18360-18367	between	_	
80-11	18368-18379	genome-wide	_	
80-12	18380-18400	psychosis-implicated	_	
80-13	18401-18408	ZNF804A	_	
80-14	18409-18418	rs1344706	_	
80-15	18419-18423	risk	_	
80-16	18424-18430	allele	_	
80-17	18431-18433	in	_	
80-18	18434-18435	a	_	
80-19	18436-18460	genotype-by-BD-diagnosis	_	
80-20	18461-18472	interaction	_	
80-21	18473-18475	on	_	
80-22	18476-18484	regional	_	
80-23	18485-18495	activation	_	
80-24	18495-18496	,	_	
80-25	18497-18500	and	_	
80-26	18501-18507	across	_	
80-27	18508-18517	psychosis	_	
80-28	18518-18526	patients	_	
80-29	18527-18530	and	_	
80-30	18531-18538	healthy	_	
80-31	18539-18546	samples	_	
80-32	18547-18551	with	_	
80-33	18552-18561	decreased	_	
80-34	18562-18572	functional	_	
80-35	18573-18585	connectivity	_	
80-36	18585-18586	,	_	
80-37	18587-18593	during	_	
80-38	18594-18600	verbal	_	
80-39	18601-18608	fluency	_	
80-40	18609-18610	–	_	
80-41	18611-18612	a	_	
80-42	18613-18617	task	_	
80-43	18618-18626	engaging	_	
80-44	18627-18632	brain	_	
80-45	18633-18640	regions	_	
80-46	18641-18644	and	_	
80-47	18645-18654	cognitive	_	
80-48	18655-18664	processes	_	
80-49	18665-18673	impaired	_	
80-50	18674-18676	in	_	
80-51	18677-18680	SCZ	_	
80-52	18681-18684	and	_	
80-53	18685-18687	BD	_	
80-54	18687-18688	.	_	

#Text=This converges with findings in other tasks, our previous finding of its widespread impact on brain white matter microstructure, and with the dysconnectivity hypothesis of SCZ.
81-1	18689-18693	This	_	
81-2	18694-18703	converges	_	
81-3	18704-18708	with	_	
81-4	18709-18717	findings	_	
81-5	18718-18720	in	_	
81-6	18721-18726	other	_	
81-7	18727-18732	tasks	_	
81-8	18732-18733	,	_	
81-9	18734-18737	our	_	
81-10	18738-18746	previous	_	
81-11	18747-18754	finding	_	
81-12	18755-18757	of	_	
81-13	18758-18761	its	_	
81-14	18762-18772	widespread	_	
81-15	18773-18779	impact	_	
81-16	18780-18782	on	_	
81-17	18783-18788	brain	_	
81-18	18789-18794	white	_	
81-19	18795-18801	matter	_	
81-20	18802-18816	microstructure	_	
81-21	18816-18817	,	_	
81-22	18818-18821	and	_	
81-23	18822-18826	with	_	
81-24	18827-18830	the	_	
81-25	18831-18846	dysconnectivity	_	
81-26	18847-18857	hypothesis	_	
81-27	18858-18860	of	_	
81-28	18861-18864	SCZ	_	
81-29	18864-18865	.	_	

#Text=References
#Text=Differential frontal activation in schizophrenia and bipolar illness during verbal fluency
#Text=Specificity of cognitive deficits in bipolar disorder versus schizophrenia
#Text=Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A
#Text=Neural mechanisms of a genome-wide supported psychosis variant
#Text=Phonology, semantics, and the role of the left inferior prefrontal cortex
#Text=Does functional MRI detect activation in white matter?
82-1	18866-18876	References	_	
82-2	18877-18889	Differential	_	
82-3	18890-18897	frontal	_	
82-4	18898-18908	activation	_	
82-5	18909-18911	in	_	
82-6	18912-18925	schizophrenia	_	
82-7	18926-18929	and	_	
82-8	18930-18937	bipolar	_	
82-9	18938-18945	illness	_	
82-10	18946-18952	during	_	
82-11	18953-18959	verbal	_	
82-12	18960-18967	fluency	_	
82-13	18968-18979	Specificity	_	
82-14	18980-18982	of	_	
82-15	18983-18992	cognitive	_	
82-16	18993-19001	deficits	_	
82-17	19002-19004	in	_	
82-18	19005-19012	bipolar	_	
82-19	19013-19021	disorder	_	
82-20	19022-19028	versus	_	
82-21	19029-19042	schizophrenia	_	
82-22	19043-19052	Cognitive	_	
82-23	19053-19058	state	_	
82-24	19059-19062	and	_	
82-25	19063-19075	connectivity	_	
82-26	19076-19083	effects	_	
82-27	19084-19086	of	_	
82-28	19087-19090	the	_	
82-29	19091-19102	genome-wide	_	
82-30	19103-19114	significant	_	
82-31	19115-19124	psychosis	_	
82-32	19125-19132	variant	_	
82-33	19133-19135	in	_	
82-34	19136-19143	ZNF804A	_	
82-35	19144-19150	Neural	_	
82-36	19151-19161	mechanisms	_	
82-37	19162-19164	of	_	
82-38	19165-19166	a	_	
82-39	19167-19178	genome-wide	_	
82-40	19179-19188	supported	_	
82-41	19189-19198	psychosis	_	
82-42	19199-19206	variant	_	
82-43	19207-19216	Phonology	_	
82-44	19216-19217	,	_	
82-45	19218-19227	semantics	_	
82-46	19227-19228	,	_	
82-47	19229-19232	and	_	
82-48	19233-19236	the	_	
82-49	19237-19241	role	_	
82-50	19242-19244	of	_	
82-51	19245-19248	the	_	
82-52	19249-19253	left	_	
82-53	19254-19262	inferior	_	
82-54	19263-19273	prefrontal	_	
82-55	19274-19280	cortex	_	
82-56	19281-19285	Does	_	
82-57	19286-19296	functional	_	
82-58	19297-19300	MRI	_	
82-59	19301-19307	detect	_	
82-60	19308-19318	activation	_	
82-61	19319-19321	in	_	
82-62	19322-19327	white	_	
82-63	19328-19334	matter	_	
82-64	19334-19335	?	_	

#Text=A review of emerging evidence, issues, and future directions
#Text=What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function?
83-1	19336-19337	A	_	
83-2	19338-19344	review	_	
83-3	19345-19347	of	_	
83-4	19348-19356	emerging	_	
83-5	19357-19365	evidence	_	
83-6	19365-19366	,	_	
83-7	19367-19373	issues	_	
83-8	19373-19374	,	_	
83-9	19375-19378	and	_	
83-10	19379-19385	future	_	
83-11	19386-19396	directions	_	
83-12	19397-19401	What	_	
83-13	19402-19404	is	_	
83-14	19405-19408	the	_	
83-15	19409-19415	impact	_	
83-16	19416-19418	of	_	
83-17	19419-19430	genome-wide	_	
83-18	19431-19440	supported	_	
83-19	19441-19445	risk	_	
83-20	19446-19454	variants	_	
83-21	19455-19458	for	_	
83-22	19459-19472	schizophrenia	_	
83-23	19473-19476	and	_	
83-24	19477-19484	bipolar	_	
83-25	19485-19493	disorder	_	
83-26	19494-19496	on	_	
83-27	19497-19502	brain	_	
83-28	19503-19512	structure	_	
83-29	19513-19516	and	_	
83-30	19517-19525	function	_	
83-31	19525-19526	?	_	

#Text=A systematic review
#Text=A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes
#Text=Genome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorder
#Text=Category fluency, latent semantic analysis and schizophrenia: a candidate gene approach
#Text=Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia
#Text=Genetic variability in the regulation of gene expression in ten regions of the human brain
#Text=Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A
#Text=Synaptic plasticity and dysconnection in schizophrenia
#Text=Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task
#Text=Effect of rs1344706 in the ZNF804A gene on the connectivity between the hippocampal formation and posterior cingulate cortex
#Text=Supplementary data
#Text=The following are the supplementary data related to this article:
#Text=Supplementary data related to this article can be found at https://doi.org/10.1016/j.jpsychires.2017.12.005.
84-1	19527-19528	A	_	
84-2	19529-19539	systematic	_	
84-3	19540-19546	review	_	
84-4	19547-19548	A	_	
84-5	19549-19562	schizophrenia	_	
84-6	19563-19567	risk	_	
84-7	19568-19572	gene	_	
84-8	19572-19573	,	_	
84-9	19574-19581	ZNF804A	_	
84-10	19581-19582	,	_	
84-11	19583-19593	influences	_	
84-12	19594-19609	neuroanatomical	_	
84-13	19610-19613	and	_	
84-14	19614-19628	neurocognitive	_	
84-15	19629-19639	phenotypes	_	
84-16	19640-19651	Genome-wide	_	
84-17	19652-19662	discovered	_	
84-18	19663-19677	psychosis-risk	_	
84-19	19678-19682	gene	_	
84-20	19683-19690	ZNF804A	_	
84-21	19691-19698	impacts	_	
84-22	19699-19701	on	_	
84-23	19702-19707	white	_	
84-24	19708-19714	matter	_	
84-25	19715-19729	microstructure	_	
84-26	19730-19732	in	_	
84-27	19733-19739	health	_	
84-28	19739-19740	,	_	
84-29	19741-19754	schizophrenia	_	
84-30	19755-19758	and	_	
84-31	19759-19766	bipolar	_	
84-32	19767-19775	disorder	_	
84-33	19776-19784	Category	_	
84-34	19785-19792	fluency	_	
84-35	19792-19793	,	_	
84-36	19794-19800	latent	_	
84-37	19801-19809	semantic	_	
84-38	19810-19818	analysis	_	
84-39	19819-19822	and	_	
84-40	19823-19836	schizophrenia	_	
84-41	19836-19837	:	_	
84-42	19838-19839	a	_	
84-43	19840-19849	candidate	_	
84-44	19850-19854	gene	_	
84-45	19855-19863	approach	_	
84-46	19864-19872	Opposite	_	
84-47	19873-19880	effects	_	
84-48	19881-19883	of	_	
84-49	19884-19912	catechol-O-methyltransferase	_	
84-50	19913-19922	Val158Met	_	
84-51	19923-19925	on	_	
84-52	19926-19934	cortical	_	
84-53	19935-19943	function	_	
84-54	19944-19946	in	_	
84-55	19947-19954	healthy	_	
84-56	19955-19963	subjects	_	
84-57	19964-19967	and	_	
84-58	19968-19976	patients	_	
84-59	19977-19981	with	_	
84-60	19982-19995	schizophrenia	_	
84-61	19996-20003	Genetic	_	
84-62	20004-20015	variability	_	
84-63	20016-20018	in	_	
84-64	20019-20022	the	_	
84-65	20023-20033	regulation	_	
84-66	20034-20036	of	_	
84-67	20037-20041	gene	_	
84-68	20042-20052	expression	_	
84-69	20053-20055	in	_	
84-70	20056-20059	ten	_	
84-71	20060-20067	regions	_	
84-72	20068-20070	of	_	
84-73	20071-20074	the	_	
84-74	20075-20080	human	_	
84-75	20081-20086	brain	_	
84-76	20087-20094	Altered	_	
84-77	20095-20103	cortical	_	
84-78	20104-20111	network	_	
84-79	20112-20120	dynamics	_	
84-80	20120-20121	:	_	
84-81	20122-20123	a	_	
84-82	20124-20133	potential	_	
84-83	20134-20146	intermediate	_	
84-84	20147-20156	phenotype	_	
84-85	20157-20160	for	_	
84-86	20161-20174	schizophrenia	_	
84-87	20175-20178	and	_	
84-88	20179-20190	association	_	
84-89	20191-20195	with	_	
84-90	20196-20203	ZNF804A	_	
84-91	20204-20212	Synaptic	_	
84-92	20213-20223	plasticity	_	
84-93	20224-20227	and	_	
84-94	20228-20241	dysconnection	_	
84-95	20242-20244	in	_	
84-96	20245-20258	schizophrenia	_	
84-97	20259-20266	Effects	_	
84-98	20267-20269	of	_	
84-99	20270-20271	a	_	
84-100	20272-20283	genome-wide	_	
84-101	20284-20293	supported	_	
84-102	20294-20303	psychosis	_	
84-103	20304-20308	risk	_	
84-104	20309-20316	variant	_	
84-105	20317-20319	on	_	
84-106	20320-20326	neural	_	
84-107	20327-20337	activation	_	
84-108	20338-20344	during	_	
84-109	20345-20346	a	_	
84-110	20347-20361	theory-of-mind	_	
84-111	20362-20366	task	_	
84-112	20367-20373	Effect	_	
84-113	20374-20376	of	_	
84-114	20377-20386	rs1344706	_	
84-115	20387-20389	in	_	
84-116	20390-20393	the	_	
84-117	20394-20401	ZNF804A	_	
84-118	20402-20406	gene	_	
84-119	20407-20409	on	_	
84-120	20410-20413	the	_	
84-121	20414-20426	connectivity	_	
84-122	20427-20434	between	_	
84-123	20435-20438	the	_	
84-124	20439-20450	hippocampal	_	
84-125	20451-20460	formation	_	
84-126	20461-20464	and	_	
84-127	20465-20474	posterior	_	
84-128	20475-20484	cingulate	_	
84-129	20485-20491	cortex	_	
84-130	20492-20505	Supplementary	_	
84-131	20506-20510	data	_	
84-132	20511-20514	The	_	
84-133	20515-20524	following	_	
84-134	20525-20528	are	_	
84-135	20529-20532	the	_	
84-136	20533-20546	supplementary	_	
84-137	20547-20551	data	_	
84-138	20552-20559	related	_	
84-139	20560-20562	to	_	
84-140	20563-20567	this	_	
84-141	20568-20575	article	_	
84-142	20575-20576	:	_	
84-143	20577-20590	Supplementary	_	
84-144	20591-20595	data	_	
84-145	20596-20603	related	_	
84-146	20604-20606	to	_	
84-147	20607-20611	this	_	
84-148	20612-20619	article	_	
84-149	20620-20623	can	_	
84-150	20624-20626	be	_	
84-151	20627-20632	found	_	
84-152	20633-20635	at	_	
84-153	20636-20641	https	_	
84-154	20641-20642	:	_	
84-155	20642-20643	/	_	
84-156	20643-20644	/	_	
84-157	20644-20651	doi.org	_	
84-158	20651-20652	/	_	
84-159	20652-20659	10.1016	_	
84-160	20659-20660	/	_	
84-161	20660-20672	j.jpsychires	_	
84-162	20672-20684	.2017.12.005	_	
84-163	20684-20685	.	_	
